Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family. Acting in an endocrine fashion, it increases glucose uptake, modulates lipid metabolism, and sensitizes insulin response in metabolically active organs, including the liver and adipose tissue. Emerging evidence shows a strong correlation between circulating FGF21 levels and the incidence and severity of atherosclerosis. Animal studies have demonstrated a beneficial role of FGF21 in protecting against aberrant lipid profile, while recent development in FGF21 mimetics has provided further insight into the lipid-lowering effects of FGF21 signaling. The present review summarizes the physiological roles of FGF21, and discusses major breakthroughs and limitations of FGF21 mimetic-based therapeutic strategies for treating atherosclerosis.

Citations

Citations to this article as recorded by  

• Higher fasting fibroblast growth factor 21 was associated with a greater decline in postprandial blood pressure
  Jane Yu Ying Ong, Kaveri Pathak, Yun Zhao, Emily Calton, Christopher M. Reid, Mario J. Soares
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(2): 102720.     CrossRef
• Potential role of fibroblast growth factor 21 in the deterioration of bone quality in impaired glucose tolerance
  D. T. W. Lui, C. H. Lee, V. W. K. Chau, C. H. Y. Fong, K. M. Y. Yeung, J. K. Y. Lam, A. C. H. Lee, W. S. Chow, K. C. B. Tan, Y. C. Woo, K. S. L. Lam
  Journal of Endocrinological Investigation.2021; 44(3): 523.     CrossRef
• FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
  Lin Xiaolong, Guo Dongmin, Mihua Liu, Wang Zuo, Hu Huijun, Tan Qiufen, Hu XueMei, Lin Wensheng, Pan Yuping, Lin Jun, Zeng Zhaolin
  Journal of Cellular and Molecular Medicine.2020; 24(9): 4992.     CrossRef
• Two-hundred-liter scale fermentation, purification of recombinant human fibroblast growth factor-21, and its anti-diabetic effects on ob/ob mice
  Qi Hui, Zhen Huang, Shucai Pang, Xuanxin Yang, Jinghang Li, Bingjie Yu, Lu Tang, Xiaokun Li, Xiaojie Wang
  Applied Microbiology and Biotechnology.2019; 103(2): 719.     CrossRef
• Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats
  Yu-Chen Shi, Wei-Wei Lu, Yue-Long Hou, Kun Fu, Feng Gan, Shu-Juan Cheng, Shao-Ping Wang, Yong-Fen Qi, Jing-Hua Liu
  Chinese Medical Journal.2018; 131(5): 532.     CrossRef

Despite all technical progress in modern diagnostic methods and treatment modalities of pheochromocytoma/paraganglioma, early consideration of the presence of these tumors remains the pivotal link towards the best possible outcome for patients. A timely diagnosis and proper treatment can prevent the wide variety of potentially catastrophic cardiovascular complications. Modern biochemical testing should include tests that offer the best available diagnostic performance, measurements of metanephrines and 3-methoxytyramine in plasma or urine. To minimize false-positive test results particular attention should be paid to pre-analytical sampling conditions. In addition to anatomical imaging by computed tomography (CT) or magnetic resonance imaging, new promising functional imaging modalities of photon emission tomography/CT using with somatostatin analogues such as ⁶⁸Ga-DOTATATE (⁶⁸Ga-labeled DOTA(0)-Tyr(3)-octreotide) will probably replace ¹²³I-MIBG (iodine-123-metaiodobenzylguanidine) in the near future. As nearly half of all pheochromocytoma patients harbor a mutation in one of the 14 tumor susceptibility genes, genetic testing and counseling should at least be considered in all patients with a proven tumor. Post-surgical annual follow-up of patients by measurements of plasma or urinary metanephrines should last for at least 10 years for timely detection of recurrent or metastatic disease. Patients with a high risk for recurrence or metastatic disease (paraganglioma, young age, multiple or large tumors, genetic background) should be followed up lifelong.

Citations

Citations to this article as recorded by  

• Three-dimensional CT cinematic rendering of adrenal masses: Role in tumor analysis and management
  Taha M. Ahmed, Steven P. Rowe, Elliot K. Fishman, Philippe Soyer, Linda C. Chu
  Diagnostic and Interventional Imaging.2024; 105(1): 5.     CrossRef
• Bone metastasis manifested 52 years after resection of an apparently benign paraganglioma: A case report
  Run Yu, Martin S Auerbach, Nathan S Honda
  SAGE Open Medical Case Reports.2024;[Epub]     CrossRef
• A case report on pheochromocytoma mimicking as fulminant myocarditis—a diagnostic challenge
  Yanwei Cheng, Ning Ding, Longan Wang, Lijie Qin
  Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
• A Case of Pheochromocytoma With Coagulation Necrosis Due to Hypertensive Crisis Aggravated by Contrast-Enhanced CT Scan and Negative 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy
  Ai Kobayashi, Yuki Ishinoda, Asuka Uto, Sho Ogata, Naoki Oshima
  Cureus.2024;[Epub]     CrossRef
• Management of Pheochromocytomas and Paragangliomas
  Jesse E. Passman, Heather Wachtel
  Surgical Clinics of North America.2024; 104(4): 863.     CrossRef
• Management of Abdominal Paraganglioma: A Single Center’s Experience
  Enrico Battistella, Luca Pomba, Marica Mirabella, Riccardo Toniato, Giuseppe Opocher, Antonio Toniato
  Medicina.2024; 60(4): 604.     CrossRef
• Head and Neck Paragangliomas: Overview of Institutional Experience
  Swar N. Vimawala, Alex Z. Graboyes, Bonita Bennett, Maria Bonanni, Aleena Abbasi, Tanaya Oliphant, Michelle Alonso-Basanta, Christopher Rassekh, Debbie Cohen, Jason A. Brant, Yonghong Huan
  Cancers.2024; 16(8): 1523.     CrossRef
• Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
  Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya
  Scientific Reports.2024;[Epub]     CrossRef
• Inferior Laryngeal Nerve Paraganglioma With Norepinephrine Hypersecretion Diagnosed Shortly After Pregnancy
  David Kishlyansky, Rithvika Ramesh, Olivia Cook, Meera Luthra
  JCEM Case Reports.2024;[Epub]     CrossRef
• Metabolomics and proteomics in pheochromocytoma and paraganglioma: Translating biochemistry and biology to bedside
  Jiri Petrak, Sergei G. Tevosian, Susan Richter, Hans K. Ghayee
  Best Practice & Research Clinical Endocrinology & Metabolism.2024; : 101935.     CrossRef
• Atypical Presentation of Pheochromocytoma: A Case Report of Ventricular Tachycardia in a Young Woman
  Gurjot Singh, Kanishka Goswami, Kanwarpreet S Sandhu, Anupam Singh, Shubam Trehan, Didar Singh
  Cureus.2024;[Epub]     CrossRef
• A dosimetric comparison of proton versus photon irradiation for paediatric glomus tumour: a case study
  Gabriel S. Vidal, Julie Arntzen, Salahuddin Ahmad, Christina Henson
  Journal of Radiotherapy in Practice.2023;[Epub]     CrossRef
• Clinical presentation and diagnostic evaluation of pheochromocytoma: case series and literature review
  Panagiota Anyfanti, Κonstantinos Mastrogiannis, Αntonios Lazaridis, Κonstantinos Tasios, Despoina Vasilakou, Αnastasia Kyriazidou, Fotios Aroutsidis, Olga Pavlidou, Εleni Papoutsopoulou, Athina Tiritidou, Vasileios Kotsis, Αreti Triantafyllou, Ιoannis Zar
  Clinical and Experimental Hypertension.2023;[Epub]     CrossRef
• Case Report: Octreotide plus CVD chemotherapy for the treatment of multiple metastatic paragangliomas after double resection for functional bladder paraganglioma and urothelial papilloma
  Zilong Wang, Feifan Liu, Chao Li, Huisheng Yuan, Yuzhu Xiang, Chunxiao Wei, Dongyuan Zhu, Muwen Wang
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
  Antonella Lucia Marretta, Alessandro Ottaiano, Domenico Iervolino, Alessandra Bracigliano, Ottavia Clemente, Francesca Di Gennaro, Roberto Tafuto, Mariachiara Santorsola, Secondo Lastoria, Salvatore Tafuto
  Journal of Clinical Medicine.2023; 12(4): 1494.     CrossRef
• Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS/MS and assessment of diagnostic performance in pheochromocytoma/paraganglioma
  Yuxin Lin, Meihua Wang, Yingping Cao
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2023; 60(3): 160.     CrossRef
• Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
  Michal Eid, Jakub Foukal, Dana Sochorová, Štěpán Tuček, Karel Starý, Zdeněk Kala, Jiří Mayer, Radim Němeček, Jan Trna, Lumír Kunovský
  Cancer Medicine.2023; 12(13): 13942.     CrossRef
• Editorial: Predictive tools in pheochromocytoma and paraganglioma
  Filippo Ceccato, Ricardo Correa, Masha Livhits, Henrik Falhammar
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Functional retroperitoneal paraganglioma invading the inferior vena cava in the elderly, a case report and literature review
  Mohamed Aymane Loukili, Imane Assarrar, Nada El Yamani, Anass Haloui, Siham Rouf, Hanane Latrech
  International Journal of Surgery Case Reports.2023; 109: 108547.     CrossRef
• Pediatric total fractionated metanephrines: age-related reference intervals in spot urine
  Laura ROLI, Agnese VERONESI, Maria C. DE SANTIS, Enrica BARALDI
  Minerva Pediatrics.2023;[Epub]     CrossRef
• An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
  Michele Bevere, Francesca Masetto, Maria Elena Carazzolo, Alice Bettega, Anastasios Gkountakos, Aldo Scarpa, Michele Simbolo
  Diagnostics.2023; 13(17): 2820.     CrossRef
• Pheochromocytoma: a changing perspective and current concepts
  Andreas Kiriakopoulos, Periklis Giannakis, Evangelos Menenakos
  Therapeutic Advances in Endocrinology and Metabolism.2023;[Epub]     CrossRef
• N-doped carbon Co/CoOx with laccase-like activity for detection of epinephrine
  Junlun Zhu, Qian Cui, Tao Long, Yijia Wang, Wei Wen, Zhengfang Tian, Xiuhua Zhang, Shengfu Wang
  Microchimica Acta.2023;[Epub]     CrossRef
• Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
  Taymeyah Al-Toubah, Jonathan Strosberg, Julie Hallanger-Johnson, Ghassan El-Haddad
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• An Atypical Presentation of Childhood Paraganglioma with Seizures: A Case Report and Review of the Literature
  Elizabeth Eberechi Oyenusi, Uzoamaka Felicia Nwigbo, Oluwadamilola Moromoke Oladipo, Blessing Ebele Kene-Udemezue, Kasarachi Pauline Akowundu, Khadijah Omobusola Oleolo-Ayodeji, Oluwaseun Adunni Afoke, Funmilayo Oluwatoyin Babatunde, Felix Makinde Alakalo
  Case Reports in Endocrinology.2023; 2023: 1.     CrossRef
• Comparison of the effectiveness of various methods for determining the level of metanephrines in the diagnosis of pheochromocytomas
  Sh. Sh. Shikhmagomedov, D. V. Rebrova, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, R. A. Chernikov, V. F. Rusakov, I. V. Slepstov, E. A. Zgoda
  Problems of Endocrinology.2023; 70(2): 46.     CrossRef
• Addition of 3‐methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy
  Lu Liu, Wenchun Xie, Zhijing Song, Tianyu Wang, Xuesong Li, Ying Gao, Yan Li, Junqing Zhang, Xiaohui Guo
  Clinical Endocrinology.2022; 96(2): 132.     CrossRef
• Hereditary and Sporadic Pheochromocytoma: Comparison of Imaging, Clinical, and Laboratory Features
  Ryan Chung, Aileen O'Shea, Ann T. Sweeney, Nathaniel D. Mercaldo, Shaunagh McDermott, Michael A. Blake
  American Journal of Roentgenology.2022; 219(1): 97.     CrossRef
• Nonvestibular Schwannomas of the Head and Neck
  A.H. Duran, M.T. Starc, A. Khorsandi
  Neurographics.2022; 12(1): 25.     CrossRef
• Preoperative Alpha-Blocker Therapy in Patients with Missed Preoperative Diagnosis of Extra-Adrenal Retroperitoneal Paraganglioma Undergoing Resection: A Retrospective Study of 167 Cases at a Single Center
  Yi Liu, Xinye Jin, Jie Gao, Shan Jiang, Lei Liu, Jingsheng Lou, Bo Wang, Hong Zhang, Qiang Fu
  Neuroendocrinology.2022; 112(5): 457.     CrossRef
• Metastatic pheochromocytomas and paragangliomas: where are we?
  Natalie Prinzi, Francesca Corti, Martina Torchio, Monica Niger, Maria Antista, Filippo Pagani, Teresa Beninato, Iolanda Pulice, Roberta Elisa Rossi, Jorgelina Coppa, Tommaso Cascella, Luca Giacomelli, Maria Di Bartolomeo, Massimo Milione, Filippo de Braud
  Tumori Journal.2022; 108(6): 526.     CrossRef
• Feocromocitoma adrenal. Claves para el diagnóstico radiológico
  M.A. Corral de la Calle, J. Encinas de la Iglesia, G.C. Fernández-Pérez, M. Repollés Cobaleda, A. Fraino
  Radiología.2022; 64(4): 348.     CrossRef
• Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review
  Stella Bernardi, Veronica Calabrò, Marco Cavallaro, Sara Lovriha, Rita Eramo, Bruno Fabris, Nicolò de Manzini, Chiara Dobrinja
  Journal of Clinical Medicine.2022; 11(14): 4064.     CrossRef
• Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years
  Abdul Rahman Al Subhi, Veronica Boyle, Marianne S Elston
  Journal of the Endocrine Society.2022;[Epub]     CrossRef
• Management of Patients with Treatment of Pheochromocytoma: A Critical Appraisal
  Florence Bihain, Claire Nomine-Criqui, Philippe Guerci, Stephane Gasman, Marc Klein, Laurent Brunaud
  Cancers.2022; 14(16): 3845.     CrossRef
• Adrenal pheochromocytoma: Keys to radiologic diagnosis
  M.A. Corral de la Calle, J. Encinas de la Iglesia, G.C. Fernández-Pérez, M. Repollés Cobaleda, A. Fraino
  Radiología (English Edition).2022; 64(4): 348.     CrossRef
• Preoperative blood pressure targets and effect on hemodynamics in pheochromocytoma and paraganglioma
  Randi Ugleholdt, Åse Krogh Rasmussen, Pernille A H Haderslev, Bjarne Kromann-Andersen, Claus Larsen Feltoft
  Endocrine Connections.2022;[Epub]     CrossRef
• Liquid chromatography–tandem mass spectrometry for clinical diagnostics
  Stefani N. Thomas, Deborah French, Paul J. Jannetto, Brian A. Rappold, William A. Clarke
  Nature Reviews Methods Primers.2022;[Epub]     CrossRef
• Acute Stress Cardiomyopathy: Heart of pheochromocytoma
  Erika Cornu, Justina Motiejunaite, Ines Belmihoub, Emmanuelle Vidal-Petiot, Mariana Mirabel, Laurence Amar
  Annales d'Endocrinologie.2021; 82(3-4): 201.     CrossRef
• Endocrine causes of heart failure: A clinical primer for cardiologists
  Saurav Khatiwada, Hiya Boro, Faraz Ahmed Farooqui, Sarah Alam
  Indian Heart Journal.2021; 73(1): 14.     CrossRef
• Recurrence Rate of Sporadic Pheochromocytomas After Curative Adrenalectomy: A Systematic Review and Meta-analysis
  Isabelle Holscher, Tijs J van den Berg, Koen M A Dreijerink, Anton F Engelsman, Els J M Nieveen van Dijkum
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): 588.     CrossRef
• Overview of Monogenic Forms of Hypertension Combined With Hypokalemia
  Yi-Ting Lu, Peng Fan, Di Zhang, Ying Zhang, Xu Meng, Qiong-Yu Zhang, Lin Zhao, Kun-Qi Yang, Xian-Liang Zhou
  Frontiers in Pediatrics.2021;[Epub]     CrossRef
• Management of the patient with incidental bilateral adrenal nodules
  Ann T. Sweeney, Padmavathi Srivoleti, Michael A. Blake
  Journal of Clinical and Translational Endocrinology: Case Reports.2021; 20: 100082.     CrossRef
• Arterial thrombosis and intracardiac thrombus as the initial presentation of a recurrent paraganglioma: case report and review of the literature
  Dania Lizet Quintanilla-Flores, Jesús Zacarías Villarreal-Pérez, Claudia Analy Vélez-Viveros, Paola Portillo-Sánchez, Adriana Josefina Ortíz-Morales, José Gerardo González-González
  Archives of Endocrinology and Metabolism.2021;[Epub]     CrossRef
• La gestione perioperatoria delle masse surrenaliche
  Filippo Ceccato, Carla Scaroni
  L'Endocrinologo.2021; 22(2): 127.     CrossRef
• Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models
  Kelly Doyle, Elizabeth L Frank
  American Journal of Clinical Pathology.2021; 156(4): 691.     CrossRef
• Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis
  Chun-Xian Chen, Dong-Ning Chen, Xiong-Lin Sun, Zhi-Bin Ke, Fei Lin, Hang Chen, Xuan Tao, Fei Huang, Yong Wei, Ning Xu
  Aging.2021; 13(7): 9976.     CrossRef
• Pheochromocytoma in a 49-year-old woman presenting with acute myocardial infarction: A case report
  Hao-Yu Wu, Yi-Wei Cao, Tian-Jiao Gao, Jian-Li Fu, Lei Liang
  World Journal of Clinical Cases.2021; 9(15): 3752.     CrossRef
• Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
  Yun Mi Choi, Jinyeong Lim, Min Ji Jeon, Yu-Mi Lee, Tae-Yon Sung, Eun-Gyoung Hong, Ji-Young Lee, Se Jin Jang, Won Gu Kim, Dong Eun Song, Sung-Min Chun
  Cancers.2021; 13(10): 2389.     CrossRef
• Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients
  Meredith L. Seamon, Ikuyo Yamaguchi
  Current Hypertension Reports.2021;[Epub]     CrossRef
• Endocrine hypertension secondary to adrenal tumors: clinical course and predictive factors of clinical remission
  Uriel Clemente-Gutiérrez, Rafael H. Pérez-Soto, Juan D. Hernández-Acevedo, Nicole M. Iñiguez-Ariza, Enrique Casanueva-Pérez, Juan Pablo Pantoja-Millán, Mauricio Sierra-Salazar, Miguel F. Herrera, David Velázquez-Fernández
  Langenbeck's Archives of Surgery.2021; 406(6): 2027.     CrossRef
• A multidisciplinary approach to the management of adrenal incidentaloma
  Giacomo Voltan, Marco Boscaro, Decio Armanini, Carla Scaroni, Filippo Ceccato
  Expert Review of Endocrinology & Metabolism.2021; 16(4): 201.     CrossRef
• Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
  Manisha H. Shah, Whitney S. Goldner, Al B. Benson, Emily Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, Jennifer Chan, Satya Das, Paxton V. Dickson, Paul Fanta, Thomas Giordano, Thorvardur R. Halfdanarson, Daniel Halperin, Jin He, Anthony Heaney, Marti
  Journal of the National Comprehensive Cancer Network.2021; 19(7): 839.     CrossRef
• Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors
  Juliane März, Max Kurlbaum, Oisin Roche-Lancaster, Timo Deutschbein, Mirko Peitzsch, Cornelia Prehn, Dirk Weismann, Mercedes Robledo, Jerzy Adamski, Martin Fassnacht, Meik Kunz, Matthias Kroiss
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Bilateral carotid paraganglioma: A case report
  Jean Michel Nzisabira, Eugène Ndirahisha, Sébastien Manirakiza, Linda Samantha Nzisabira, Patrice Barasukana, Léopold Nzisabira
  International Journal of Case Reports and Images.2021; 12: 1.     CrossRef
• An Overview on Pheochromocytoma Diagnosis and Management Approach, Review Article
  Yazeed Ali Aljabri, Faris Sami Alghamdi, Khaled Ahmed Almehmadi, Abdulrahman Abubaker Babkoor, Abdulhafiz Muhammad Bahalaq, Anwar Aziz Althaqfi, Abdullah Ghazi Alharbi, Rayan Saud Alhazmi, Ahmad Ali Almalki
  World Journal of Environmental Biosciences.2021; 10(3): 18.     CrossRef
• Bladder paraganglioma: CT and MR imaging characteristics in 16 patients
  Jing Zhang, Xu Bai, Jing Yuan, Xiaojing Zhang, Wei Xu, Huiyi Ye, Haiyi Wang
  Radiology and Oncology.2021; 56(1): 46.     CrossRef
• Laparoscopic Partial Resection of Retroperitoneal Extramedullary Plasmacytoma
  Andrzej Gasz, Jan Danko, Maros Straka, Lazo Ilic, José M. Ramia
  Cirugía Española (English Edition).2020; 98(5): 299.     CrossRef
• Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
  Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
  Endocrinology and Metabolism.2020; 35(1): 157.     CrossRef
• Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy
  Mirko Parasiliti-Caprino, Barbara Lucatello, Chiara Lopez, Jacopo Burrello, Francesca Maletta, Marinella Mistrangelo, Enrica Migliore, Francesco Tassone, Antonio La Grotta, Anna Pia, Giuseppe Reimondo, Roberta Giordano, Giuseppe Giraudo, Alessandro Pioves
  Hypertension Research.2020; 43(6): 500.     CrossRef
• A Brief Overview of the Epidemiology of Pheochromocytoma and Paraganglioma in Korea
  Yun Mi Choi
  Endocrinology and Metabolism.2020; 35(1): 95.     CrossRef
• Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management
  Amrish Jain, Rossana Baracco, Gaurav Kapur
  Pediatric Nephrology.2020; 35(4): 581.     CrossRef
• Short-term stability of free metanephrines in plasma and whole blood
  Elisa Danese, Martina Montagnana, Claudio Brentegani, Giuseppe Lippi
  Clinical Chemistry and Laboratory Medicine (CCLM).2020; 58(5): 753.     CrossRef
• Meta-analysis of α-blockade versus no blockade before adrenalectomy for phaeochromocytoma
  S Schimmack, J Kaiser, P Probst, E Kalkum, M K Diener, O Strobel
  British Journal of Surgery.2020; 107(2): e102.     CrossRef
• In Matrix Derivatization Combined with LC-MS/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines
  Martijn van Faassen, Rainer Bischoff, Karin Eijkelenkamp, Wilhelmina H. A. de Jong, Claude P. van der Ley, Ido P. Kema
  Analytical Chemistry.2020; 92(13): 9072.     CrossRef
• Resección parcial laparoscópica de plasmocitoma extramedular retroperitoneal
  Andrzej Gasz, Jan Danko, Maros Straka, Lazo Ilic, José M. Ramia
  Cirugía Española.2020; 98(5): 299.     CrossRef
• Bladder Preservation for Patients With Bladder Paragangliomas: Case Series and Review of the Literature
  Elizabeth Y. Wang, Jamie S. Pak, Renu K. Virk, Christopher B. Anderson, Kelly A. Healy, James A. Lee, Mitchell C. Benson, James M. McKiernan
  Urology.2020; 143: 194.     CrossRef
• Decision-Making in Artificial Intelligence: Is It Always Correct?
  Hun-Sung Kim
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Pheochromocytoma and Paraganglioma
  James K. Moon, Peter Mattei
  Seminars in Pediatric Surgery.2020; 29(3): 150926.     CrossRef
• 52-Year-Old Woman With Fever, Diaphoresis, and Abdominal Pain
  Thomas J. Breen, Brenden S. Ingraham, Jacob C. Jentzer
  Mayo Clinic Proceedings.2020; 95(7): e69.     CrossRef
• Diagnostic des phéochromocytomes et paragangliomes
  F. Castinetti, A. Barlier, F. Sebag, D. Taieb
  Oncologie.2020;[Epub]     CrossRef
• Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
  Georgiana Constantinescu, Katharina Langton, Catleen Conrad, Laurence Amar, Guillaume Assié, Anne-Paule Gimenez-Roqueplo, Anne Blanchard, Casper K Larsen, Paolo Mulatero, Tracy Ann Williams, Aleksander Prejbisz, Martin Fassnacht, Stefan Bornstein, Filippo
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(9): e3374.     CrossRef
• PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway
  Xiaohua Zhang, Shan Zhong
  Anti-Cancer Agents in Medicinal Chemistry.2020; 20(7): 828.     CrossRef
• ‘Case of the month’ from UConn Health, Farmington, CT, USA: management of a giant paraganglioma
  Vikram Lyall, Michael E. Goltzman, Mina L. Boutrous, Ravali Nallu, Peter C. Albertsen, Beatriz E. Tendler, Benjamin T. Ristau
  BJU International.2020; 126(5): 551.     CrossRef
• Perioperative management of pheocromocytoma/ paraganglioma: a comprehensive review
  Alejandro Román-González, Huber Padilla-Zambrano, Luis Felipe Vásquez Jimenez
  Colombian Journal of Anesthesiology.2020;[Epub]     CrossRef
• Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
  Laura Gieldon, Doreen William, Karl Hackmann, Winnie Jahn, Arne Jahn, Johannes Wagner, Andreas Rump, Nicole Bechmann, Svenja Nölting, Thomas Knösel, Volker Gudziol, Georgiana Constantinescu, Jimmy Masjkur, Felix Beuschlein, Henri JLM Timmers, Letizia Canu
  Cancers.2019; 11(6): 809.     CrossRef
• Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma
  Ondřej Petrák, Ján Rosa, Robert Holaj, Branislav Štrauch, Zuzana Krátká, Jan Kvasnička, Judita Klímová, Petr Waldauf, Barbora Hamplová, Alice Markvartová, Květoslav Novák, David Michalský, Jiří Widimský, Tomáš Zelinka
  The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5170.     CrossRef
• Expression of PDK1 in malignant pheochromocytoma as a new promising potential therapeutic target
  X. Zhang, Z. Yu
  Clinical and Translational Oncology.2019; 21(10): 1312.     CrossRef
• Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and
  Saurabh Arora, Rakesh Kumar, Averilicia Passah, Madhavi Tripathi, Sandeep Agarwala, Rajesh Khadgawat, Chandrasekhar Bal
  Nuclear Medicine Communications.2019; 40(12): 1230.     CrossRef
• Combinatorial Inhibition of mTORC2 and Hsp90 Leads to a Distinctly Effective Therapeutic Strategy in Malignant Pheochromocytoma
  Xiaohua Zhang, Fengbin Gao, Shan Zhong
  Current Cancer Drug Targets.2019; 19(9): 698.     CrossRef
• Ischémie aiguë du membre inférieur et acidocétose diabétique révélant un phéochromocytome
  Kamal Ahsayan, Amine Ghalem, Mohammed Bouziane, Noha El Ouafi, Brahim Housni
  Anesthésie & Réanimation.2019; 5(4): 337.     CrossRef
• Enfoque diagnóstico de feocromocitomas y paragangliomas
  R.M. Gómez, M. Hernaiz, V. de Miguel, L.S. Aparicio, M.J. Marín, S. Lupi, M. Barontini
  Hipertensión y Riesgo Vascular.2019; 36(1): 34.     CrossRef
• Phéochromocytome et paragangliome
  E. Cornu, I. Belmihoub, N. Burnichon, C. Grataloup, F. Zinzindohoué, S. Baron, E. Billaud, M. Azizi, A.-P. Gimenez-Roqueplo, L. Amar
  La Revue de Médecine Interne.2019; 40(11): 733.     CrossRef
• Rendimiento de las metanefrinas libres plasmáticas en el diagnóstico de los feocromocitomas y paragangliomas en la población asturiana
  Eduardo Martínez-Morillo, Nuria Valdés Gallego, Edwin Eguia Ángeles, Juan Carlos Fernández Fernández, Belén Prieto García, Francisco V. Álvarez
  Endocrinología, Diabetes y Nutrición.2019; 66(5): 312.     CrossRef
• The Identification of Differentially Expressed Genes Showing Aberrant Methylation Patterns in Pheochromocytoma by Integrated Bioinformatics Analysis
  Dengqiang Lin, Jinglai Lin, Xiaoxia Li, Jianping Zhang, Peng Lai, Zhifeng Mao, Li Zhang, Yu Zhu, Yujun Liu
  Frontiers in Genetics.2019;[Epub]     CrossRef
• Pharmacological and analytical interference in hormone assays for diagnosis of adrenal incidentaloma
  Antoine-Guy Lopez, François Fraissinet, Herve Lefebvre, Valéry Brunel, Frédéric Ziegler
  Annales d'Endocrinologie.2019; 80(4): 250.     CrossRef
• Analysis of Short-term Blood Pressure Variability in Pheochromocytoma/Paraganglioma Patients
  Valeria Bisogni, Luigi Petramala, Gaia Oliviero, Maria Bonvicini, Martina Mezzadri, Federica Olmati, Antonio Concistrè, Vincenza Saracino, Monia Celi, Gianfranco Tonnarini, Gino Iannucci, Giorgio De Toma, Antonio Ciardi, Giuseppe La Torre, Claudio Letizia
  Cancers.2019; 11(5): 658.     CrossRef
• Imaging Features of Succinate Dehydrogenase–deficient Pheochromocytoma-Paraganglioma Syndromes
  Samuel Joseph Withey, Stephen Perrio, Dimitra Christodoulou, Louise Izatt, Paul Carroll, Anand Velusamy, Rupert Obholzer, Valerie Lewington, Audrey Eleanor Therese Jacques
  RadioGraphics.2019; 39(5): 1393.     CrossRef
• A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
  Agnieszka Kolasinska-Ćwikła, Mariola Pęczkowska, Jarosław Ćwikła, Ilona Michałowska, Jakub Pałucki, Lisa Bodei, Anna Lewczuk-Myślicka, Andrzej Januszewicz
  Journal of Clinical Medicine.2019; 8(7): 952.     CrossRef
• A Branching Algorithm
  Elisabeth Pedersen, Gurpreet Dhaliwal, Ashwin Gupta, Tobias Else, Robert Chang, Nathan Houchens
  Journal of Hospital Medicine.2019; 14(11): 707.     CrossRef
• Liquid chromatography tandem mass spectrometry for plasma metadrenalines
  S.L. Davies, A.S. Davison
  Clinica Chimica Acta.2019; 495: 512.     CrossRef
• Addressing delays in the diagnosis of pheochromocytoma/paraganglioma
  Ioannis Ilias, Costas Thomopoulos
  Expert Review of Endocrinology & Metabolism.2019; 14(5): 359.     CrossRef
• Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias
  Eduardo Martínez-Morillo, Nuria Valdés Gallego, Edwin Eguia Ángeles, Juan Carlos Fernández Fernández, Belén Prieto García, Francisco V. Álvarez
  Endocrinología, Diabetes y Nutrición (English ed.).2019; 66(5): 312.     CrossRef
• A Case of Sudden Death: Subarachnoid Hemorrhage, Pheochromocytoma, Berry Aneurysm
  Ana B. Arevalo, Jacxelyn Moran, Stephen Zink, Binny Khandakar
  Case Reports in Pathology.2019; 2019: 1.     CrossRef
• Pheochromocytoma
  Frederick-Anthony Farrugia, Anestis Charalampopoulos
  Endocrine Regulations.2019; 53(3): 191.     CrossRef
• What's New in Endocrinology: The Chromaffin Cell
  Lee E. Eiden, Sunny Zhihong Jiang
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Pheochromocytoma: A Genetic And Diagnostic Update
  Leilani B. Mercado-Asis, Katherine I. Wolf, Ivana Jochmanova, David Taïeb
  Endocrine Practice.2018; 24(1): 78.     CrossRef
• Retroperitoneal Paraganglioma Involving the Renal Hilum: A Case Report and Literature Review
  Peter Yincheng Cai, Ron Golan, Brent Yanke
  Urology.2018; 122: 24.     CrossRef
• Fluorescent ternary complexes of some biogenic amines and their metabolites with europium and oxytetracycline for applications in the chemical analysis
  Maria I. Makedonskaya, Anastasiya M. Mikhailova, Irina A. Veselova, Junji Fukuda, Tatyana N. Shekhovtsova
  Mendeleev Communications.2018; 28(5): 553.     CrossRef
• Phéochromocytomes et paragangliomes génétiquement déterminés: quelle conduite à tenir chez les apparentés ?
  Marie Vermalle, Antoine Tabarin, Frederic Castinetti
  Annales d'Endocrinologie.2018; 79: S10.     CrossRef
• Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paraganglioma
  Liang Wang, Ying Li, Xin Guan, Jingyuan Zhao, Liming Shen, Jing Liu
  Molecular Cancer.2018;[Epub]     CrossRef
• Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
  Martin Ullrich, Josephine Liers, Mirko Peitzsch, Anja Feldmann, Ralf Bergmann, Ulrich Sommer, Susan Richter, Stefan R Bornstein, Michael Bachmann, Graeme Eisenhofer, Christian G Ziegler, Jens Pietzsch
  Endocrine-Related Cancer.2018; 25(12): 993.     CrossRef
• Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor
  Marco Grasso, Marco Boscaro, Carla Scaroni, Filippo Ceccato
  High Blood Pressure & Cardiovascular Prevention.2018; 25(4): 345.     CrossRef
• Amperometric Determination of Catecholamines by Enzymatic Biosensors in Flow Systems
  Oksana Josypčuk, Jiří Barek, Bohdan Josypčuk
  Electroanalysis.2018; 30(6): 1163.     CrossRef
• Trace Amines and Their Receptors
  Raul R. Gainetdinov, Marius C. Hoener, Mark D. Berry, Jeffrey M. Witkin
  Pharmacological Reviews.2018; 70(3): 549.     CrossRef
• Methods of Paraclinic Diagnosis of Catecholamine Secreting Tumours, Especially of Pheochromocytoma
  Florin Mitu, Alexandra Maștaleru, Clementina Cojocaru, Mihai Roca, Ovidiu Mitu, Maria-Magdalena Leon-Constantin
  Internal Medicine.2018; 15(2): 31.     CrossRef

Management of pituitary tumors is multidisciplinary, with medical therapy playing an increasingly important role. With the exception of prolactin-secreting tumors, surgery is still considered the first-line treatment for the majority of pituitary adenomas. However, medical/pharmacological therapy plays an important role in controlling hormone-producing pituitary adenomas, especially for patients with acromegaly and Cushing disease (CD). In the case of non-functioning pituitary adenomas (NFAs), pharmacological therapy plays a minor role, the main objective of which is to reduce tumor growth, but this role requires further studies. For pituitary carcinomas and atypical adenomas, medical therapy, including chemotherapy, acts as an adjuvant to surgery and radiation therapy, which is often required to control these aggressive tumors. In the last decade, knowledge about the pathophysiological mechanisms of various pituitary adenomas has increased, thus novel medical therapies that target specific pathways implicated in tumor synthesis and hormonal over secretion are now available. Advancement in patient selection and determination of prognostic factors has also helped to individualize therapy for patients with pituitary tumors. Improvements in biochemical and “tumor mass” disease control can positively affect patient quality of life, comorbidities and overall survival. In this review, the medical armamentarium for treating CD, acromegaly, prolactinomas, NFA, and carcinomas/aggressive atypical adenomas will be presented. Pharmacological therapies, including doses, mode of administration, efficacy, adverse effects, and use in special circumstances are provided. Medical therapies currently under clinical investigation are also briefly discussed.

Citations

Citations to this article as recorded by  

• Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
  Kyungwon Kim, Cheol Ryong Ku, Eun Jig Lee
  Endocrinology and Metabolism.2023; 38(5): 463.     CrossRef
• PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling
  Jingdian Liu, Junwen Wang, Weidong Tian, Yu Xu, Ran Li, Kai Zhao, Chao You, Yuan Zhu, Joerg Walter Bartsch, Hongquan Niu, Huaqiu Zhang, Kai Shu, Ting Lei
  Aging.2022; 14(15): 6066.     CrossRef
• LncRNA MYMLR promotes pituitary adenoma development by upregulating carbonyl reductase 1 via sponging miR-197-3p
  Tuo Wang, Ping Mao, Yan Zhang, Bo Cui, Mao-De Wang, Ya Li, Ke Gao
  Anti-Cancer Drugs.2022; 33(10): 1058.     CrossRef
• Comparative Proteomic Study Shows the Expression of Hint-1 in Pituitary Adenomas
  Carolina Carrillo-Najar, Daniel Rembao-Bojórquez, Martha L. Tena-Suck, Sergio Zavala-Vega, Noemí Gelista-Herrera, Miguel A. Ramos-Peek, Juan L. Gómez-Amador, Febe Cazares-Raga, Fidel de la Cruz Hernández-Hernández, Alma Ortiz-Plata
  Diagnostics.2021; 11(2): 330.     CrossRef
• Recent Understanding and Future Directions of Recurrent Corticotroph Tumors
  José Miguel Hinojosa-Amaya, César Ernesto Lam-Chung, Daniel Cuevas-Ramos
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• What to Do with Incidentally Discovered Pituitary Abnormalities?
  Fabienne Langlois, Maria Fleseriu
  Medical Clinics of North America.2021; 105(6): 1081.     CrossRef
• Aggressive prolactinoma (Review)
  Ana Valea, Florica Sandru, Aida Petca, Mihai Dumitrascu, Mara Carsote, Razvan-Cosmin Petca, Adina Ghemigian
  Experimental and Therapeutic Medicine.2021;[Epub]     CrossRef
• Diagnosis and Treatment of Pituitary Adenomas
  O. A. Beylerli, Zhao Shiguang, I. F. Gareev, Chen Xin
  Creative surgery and oncology.2020; 9(4): 311.     CrossRef
• Management of patients with persistent or recurrent Cushing’s disease after initial pituitary surgery
  Cristina Capatina, José Miguel Hinojosa-Amaya, Catalina Poiana, Maria Fleseriu
  Expert Review of Endocrinology & Metabolism.2020; 15(5): 321.     CrossRef
• Modern principles of the diagnosis and conservative treatment of Cushing disease
  Ashraf Abdali, Ludmila Astafeva, Pavel Kalinin, Yuriy Trunin, I. V. Chernov, G. E. Сhmutin, Abdali Badshahzar, GulSharif Sherzad, Simfukwe Keith
  Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery).2020; (10): 67.     CrossRef
• Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line
  Jung Soo Lim, Young Woo Eom, Eun Soo Lee, Hyeong Ju Kwon, Ja-Young Kwon, Junjeong Choi, Choon Hee Chung, Young Suk Jo, Eun Jig Lee
  Endocrinology and Metabolism.2019; 34(3): 302.     CrossRef
• Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us?
  Domenico Solari, Rosario Pivonello, Chiara Caggiano, Elia Guadagno, Carmela Chiaramonte, Giovanni Miccoli, Luigi M. Cavallo, Marialaura Del Basso De Caro, Annamaria Colao, Paolo Cappabianca
  World Neurosurgery.2019; 127: 695.     CrossRef
• Expression of Cyclin E/Cdk2/p27Kip1 in Growth Hormone Adenomas
  Wei Dong, Haibo Zhu, Hua Gao, Wenjian Shi, Yu Zhang, Hongyun Wang, Chuzhong Li, Guidong Song, Yazhuo Zhang
  World Neurosurgery.2019; 121: e45.     CrossRef
• Acromegaly
  Annamaria Colao, Ludovica F. S. Grasso, Andrea Giustina, Shlomo Melmed, Philippe Chanson, Alberto M. Pereira, Rosario Pivonello
  Nature Reviews Disease Primers.2019;[Epub]     CrossRef
• Differenzialdiagnostik und Therapie der Hypophysenadenome
  M. Hlaváč, F. Sommer, G. Karpel-Massler, R. Wirtz, T. Hoffmann, A. Paľa
  HNO.2019; 67(4): 307.     CrossRef
• Medical Management of Cushing’s Syndrome: Current and Emerging Treatments
  José Miguel Hinojosa-Amaya, Daniel Cuevas-Ramos, Maria Fleseriu
  Drugs.2019; 79(9): 935.     CrossRef
• Aggressive and Malignant Prolactinomas
  Nicoleta Cristina Olarescu, Luis G. Perez-Rivas, Federico Gatto, Thomas Cuny, Maria A. Tichomirowa, Gianluca Tamagno, Manuel D. Gahete
  Neuroendocrinology.2019; 109(1): 57.     CrossRef
• New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
  Mariana Fuertes, Julieta Tkatch, Josefina Rosmino, Leandro Nieto, Mirtha Adriana Guitelman, Eduardo Arzt
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Prenatal alcohol exposure increases the susceptibility to develop aggressive prolactinomas in the pituitary gland
  Shaima Jabbar, Kenneth Reuhl, Dipak K. Sarkar
  Scientific Reports.2018;[Epub]     CrossRef
• Aggressive and malignant pituitary tumours: state-of-the-art
  Dorota Dworakowska, Ashley B Grossman
  Endocrine-Related Cancer.2018; 25(11): R559.     CrossRef
• Epidemiología y caracterización general de los tumores cerebrales primarios en el adulto
  Maria Isabel Ocampo Navia, Juan Carlos Gómez Vega, Oscar Hernando Feo Lee
  Universitas Médica.2018;[Epub]     CrossRef
• Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway
  Junwen Wang, Zhuo Zhang, Ran Li, Wei Sun, Juan Chen, Huaqiu Zhang, Kai Shu, Ting Lei
  Life Sciences.2018; 194: 150.     CrossRef
• Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers
  Danyang Shen, Xiaoming Yu, Yan Wu, Yuanlei Chen, Gonghui Li, Feng Cheng, Liqun Xia
  Expert Review of Anticancer Therapy.2018; 18(5): 487.     CrossRef
• New Molecular Targets for Treatment of Cushing’s Disease
  Elizabeth Foulkes, John Newell-Price
  Endocrinology and Metabolism Clinics of North America.2018; 47(2): 367.     CrossRef
• Pituitary-Directed Therapies for Cushing’s Disease
  Fabienne Langlois, Jennifer Chu, Maria Fleseriu
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Updates in Diagnosis and Treatment of Acromegaly
  Roula Zahr, Maria Fleseriu
  European Endocrinology.2018; 14(2): 57.     CrossRef
• Root cause analysis of diagnostic and surgical failures in the treatment of suspected Cushing’s disease
  Hasan A. Zaidi, David L. Penn, David J. Cote, Edward R. Laws
  Journal of Clinical Neuroscience.2018; 53: 153.     CrossRef

The proposal that diabetes plays a role in the development of heart failure is supported by the increased risk associated with this disease, even after correcting for all other known risk factors. However, the precise mechanisms contributing to the condition referred to as diabetic cardiomyopathy have remained elusive, as does defining the disease itself. Decades of study have defined numerous potential factors that each contribute to disease susceptibility, progression, and severity. Many recent detailed reviews have been published on mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors. As such, the focus of the current review is to highlight aspects of each of these topics and to provide specific examples of recent advances in each area.

Citations

Citations to this article as recorded by  

• Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications
  Prabhnain Kaur, Ritu Dahiya, Mukesh Nandave, Kalicharan Sharma, Ramesh K. Goyal
  Cell Biochemistry and Function.2024;[Epub]     CrossRef
• Upregulation of PCSK9, rho kinase and cardiac troponin by Eucalyptus globulus leaf extract improves fructose-streptozotocin-induced diabetic cardiac dysfunction in rats
  Afolabi C. Akinmoladun, Morenikejimi Bello, Emmanuel Oluwafemi Ibukun
  Archives of Physiology and Biochemistry.2023; 129(6): 1219.     CrossRef
• An Overview of Cardiotonic Medicinal Plants from the Perspective of Iranian Traditional Medicine
  Akram Alembagheri, Homa Hajimehdipoor, Rasool Choopani, Somayeh Esmaeili
  Jundishapur Journal of Natural Pharmaceutical Products.2023;[Epub]     CrossRef
• Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications
  Ana R. Nunes, Elisabete C. Costa, Gilberto Alves, Luís R. Silva
  Pharmaceuticals.2023; 16(5): 736.     CrossRef
• Cyp2e1 knockdown attenuates high glucose-induced apoptosis and oxidative stress of cardiomyocytes by activating PI3K/Akt signaling
  Jianying Wang, Han Yang, Chao Wang, Cuie Kan
  Acta Diabetologica.2023; 60(9): 1219.     CrossRef
• Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
  Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li
  World Journal of Hepatology.2023; 15(6): 786.     CrossRef
• Non-Invasive Assessment of the Intraventricular Pressure Using Novel Color M-Mode Echocardiography in Animal Studies: Current Status and Future Perspectives in Veterinary Medicine
  Ahmed S. Mandour, Ahmed Farag, Mahmoud A. Y. Helal, Gamal El-Masry, Salim Al-Rejaie, Ken Takahashi, Tomohiko Yoshida, Lina Hamabe, Ryou Tanaka
  Animals.2023; 13(15): 2452.     CrossRef
• Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
  Bongeka Cassandra Mkhize, Palesa Mosili, Phikelelani Sethu Ngubane, Ntethelelo Hopewell Sibiya, Andile Khathi
  Journal of Diabetes Investigation.2022; 13(5): 768.     CrossRef
• Knowledge domain and emerging trends in diabetic cardiomyopathy: A scientometric review based on CiteSpace analysis
  Shiyi Tao, Deshuang Yang, Lanxin Zhang, Lintong Yu, Zihan Wang, Lingling Li, Jin Zhang, Ruiqi Yao, Li Huang, Mingjing Shao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors
  Joshua J Neumiller, Fredrick J Lienhard, Radica Z Alicic, Katherine R Tuttle
  European Endocrinology.2022; 18(2): 106.     CrossRef
• Protective effects of medicinal plant against diabetes induced cardiac disorder: A review
  Sadegh Shabab, Zahra Gholamnezhad, Maryam Mahmoudabady
  Journal of Ethnopharmacology.2021; 265: 113328.     CrossRef
• Toward a broader view of mechanisms of drug cardiotoxicity
  Polina Mamoshina, Blanca Rodriguez, Alfonso Bueno-Orovio
  Cell Reports Medicine.2021; 2(3): 100216.     CrossRef
• Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats
  Vikram Thakur, Narah Alcoreza, Monica Delgado, Binata Joddar, Munmun Chattopadhyay
  Biomolecules.2021; 11(4): 569.     CrossRef
• Cardioprotective Action of Glycyrrhizin on Diabetic Rats with Myocardial Remodeling
  Fuxu Chen, Jie Song, Enas Abdulhay
  Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
• Management of inflammation in cardiovascular diseases
  Sumanta Kumar Goswami, Prabhat Ranjan, Roshan Kumar Dutta, Suresh Kumar Verma
  Pharmacological Research.2021; 173: 105912.     CrossRef
• Diabetic Cardiomyopathy: Clinical and Metabolic Approach
  Dragan B. Djordjevic, Goran Koracevic, Aleksandar D. Djordjevic, Dragan B. Lovic
  Current Vascular Pharmacology.2021; 19(5): 487.     CrossRef
• Effect of Acute Chemotherapy on Glucose Levels in Rats
  Ahmad H. Alhowail, Gena S. Alfawzan, Maha A. Aldubayan, Lolwah S. Alsalam
  International Journal of Pharmacology.2020; 16(3): 276.     CrossRef
• Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity
  Sijing Liu, Yi Li, Xin Fan, Kai Li, Chunrong Xu, Liping Zhang, Mao Luo, Liqun Wang, Rong Li, Jianbo Wu
  Adipocyte.2020; 9(1): 170.     CrossRef
• Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
  Jeffrey I. Mechanick, Michael E. Farkouh, Jonathan D. Newman, W. Timothy Garvey
  Journal of the American College of Cardiology.2020; 75(5): 525.     CrossRef
• Associated Targets of the Antioxidant Cardioprotection of Ganoderma lucidum in Diabetic Cardiomyopathy by Using Open Targets Platform: A Systematic Review
  Fahmi Shaher, Hongbin Qiu, Shuqiu Wang, Yu Hu, Weiqun Wang, Yu Zhang, Yao Wei, Hisham AL-ward, Mahfoudh A. M. Abdulghani, Sattam Khulaif Alenezi, Salem Baldi, Shaobo Zhou
  BioMed Research International.2020; 2020: 1.     CrossRef
• Human trophoblast-derived exosomes attenuate doxorubicin-induced cardiac injury by regulating miR-200b and downstream Zeb1
  Jie Ni, Yihai Liu, Lina Kang, Lian Wang, Zhonglin Han, Kun Wang, Biao Xu, Rong Gu
  Journal of Nanobiotechnology.2020;[Epub]     CrossRef
• Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Glucagon-like Peptide-1 Receptor Agonists
  Emily J Cox, Radica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
  US Endocrinology.2020; 16(2): 80.     CrossRef
• Hyperbaric Oxygen Therapy Dampens Inflammatory Cytokine Production and Does Not Worsen the Cardiac Function and Oxidative State of Diabetic Rats
  Rita Benkő, Zsuzsanna Miklós, Viktor Antal Ágoston, Katrine Ihonvien, Csaba Répás, Roland Csépányi-Kömi, Margit Kerék, Nóra Judit Béres, Eszter Mária Horváth
  Antioxidants.2019; 8(12): 607.     CrossRef
• Heart Failure in Type 2 Diabetes Mellitus
  Helena C. Kenny, E. Dale Abel
  Circulation Research.2019; 124(1): 121.     CrossRef
• SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
  Damilola D. Adingupu, Sven O. Göpel, Julia Grönros, Margareta Behrendt, Matus Sotak, Tasso Miliotis, Ulrika Dahlqvist, Li-Ming Gan, Ann-Cathrine Jönsson-Rylander
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus
  Paul J. Mills, Pam R. Taub, Ottar Lunde, Meredith A. Pung, Kathleen Wilson, Christopher Pruitt, Thomas Rutledge, Alan Maisel, Barry H. Greenberg
  Clinical Cardiology.2019; 42(6): 637.     CrossRef
• Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
  Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
  Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
• The Janus face of HMGB1 in heart disease: a necessary update
  Angela Raucci, Stefania Di Maggio, Francesco Scavello, Alessandro D’Ambrosio, Marco E. Bianchi, Maurizio C. Capogrossi
  Cellular and Molecular Life Sciences.2019; 76(2): 211.     CrossRef
• Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model
  Sabri Sudirman, Ching-Shu Lai, Yi-Ling Yan, Hung-I Yeh, Zwe-Ling Kong
  Scientific Reports.2019;[Epub]     CrossRef
• Microarray profiling analysis identifies the mechanism of miR‐200b‐3p/mRNA‐CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor‐γ signaling pathway
  Liqiong Xu, Wei Chen, Min Ma, Anfang Chen, Chengyue Tang, Chengwei Zhang, Lin Cai
  Journal of Cellular Biochemistry.2019; 120(4): 5193.     CrossRef
• Plasma Low-Density Lipoprotein Cholesterol Correlates With Heart Function in Individuals With Type 2 Diabetes Mellitus: A Cross-Sectional Study
  Po-Chung Cheng, Shang-Ren Hsu, Jung-Chi Li, Ching-Pei Chen, Szu-Chi Chien, Shih-Te Tu, Yun-Chung Cheng, Yu-Hsiu Liu, Jeng-Fu Kuo
  Frontiers in Endocrinology.2019;[Epub]     CrossRef
• Impact of diabetes mellitus on the contractile properties of the left and right atrial myofilaments†
  Constanze Bening, Khaled Alhussini, Elena-Aura Mazalu, Jonathan Yaqub, Khaled Hamouda, Dejan Radakovic, Christoph Schimmer, Grzegorz Hirnle, Rainer Leyh
  European Journal of Cardio-Thoracic Surgery.2018; 54(5): 826.     CrossRef
• LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling
  Lu Gao, Yuan Liu, Sen Guo, Lili Xiao, Leiming Wu, Zheng Wang, Cui Liang, Rui Yao, Yanzhou Zhang
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(10): 3322.     CrossRef
• Gene expression profiles of rat MMECs with different glucose levels and fgl2 gene silencing
  Zhenzhong Zheng, Fan Zhang, Dengpeng Gao, Yujing Wu, Hao Wu
  Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
• Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
  Kwong-Man Ng, Yee-Man Lau, Vidhu Dhandhania, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Hung-Fat Tse, Chung-Wah Siu
  Scientific Reports.2018;[Epub]     CrossRef
• Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet
  Meng Li, Huijuan Fang, Jian Hu
  Molecular Medicine Reports.2018;[Epub]     CrossRef
• Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
  Kaviyarasi Renu, V.G. Abilash, P.B. Tirupathi Pichiah, Thabassum Akthar Syeda, Sankarganesh Arunachalam
  Asian Pacific Journal of Tropical Biomedicine.2017; 7(11): 1041.     CrossRef

Glucocorticoids are widely used as potent anti-inflammatory and immunosuppressive drugs to treat a wide range of diseases. However, they are also associated with a number of side effects, including new-onset hyperglycemia in patients without a history of diabetes mellitus (DM) or severely uncontrolled hyperglycemia in patients with known DM. Glucocorticoid-induced diabetes mellitus (GIDM) is a common and potentially harmful problem in clinical practice, affecting almost all medical specialties, but is often difficult to detect in clinical settings. However, scientific evidence is lacking regarding the effects of GIDM, as well as strategies for prevention and treatment. Similarly to nonsteroid-related DM, the principles of early detection and risk factor modification apply. Screening for GIDM should be considered in all patients treated with medium to high doses of glucocorticoids. Challenges in the management of GIDM stem from wide fluctuations in postprandial hyperglycemia and the lack of clearly defined treatment protocols. Together with lifestyle measures, hypoglycemic drugs with insulin-sensitizing effects are indicated. However, insulin therapy is often unavoidable, to the point that insulin can be considered the drug of choice. The treatment of GIDM should take into account the degree and pattern of hyperglycemia, as well as the type, dose, and schedule of glucocorticoid used. Moreover, it is essential to instruct the patient and/or the patient's family about how to perform the necessary adjustments. Prospective studies are needed to answer the remaining questions regarding GIDM.

Citations

Citations to this article as recorded by  

• Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases
  Monika Kleinhans, Lea Jessica Albrecht, Sven Benson, Dagmar Fuhrer, Joachim Dissemond, Susanne Tan
  Journal of Diabetes Science and Technology.2024; 18(4): 904.     CrossRef
• COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms
  Mohsen Pourazizi, Atousa Hakamifard, Alireza Peyman, Rasoul Mohammadi, Shakiba Dehghani, Najmeh Tavousi, Nastaran‐Sadat Hosseini, Hamed Azhdari Tehrani, Bahareh Abtahi‐Naeini
  Parasite Immunology.2024;[Epub]     CrossRef
• Drug-induced hyperglycemia and diabetes
  Marie-Anne Heurtebize, Jean-Luc Faillie
  Therapies.2024; 79(2): 221.     CrossRef
• Immunosuppression in solid organ–transplant recipients and impact on nutrition support
  Nicole K. Wilson, Ann D. Kataria
  Nutrition in Clinical Practice.2024; 39(1): 109.     CrossRef
• The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes
  Vaishali Limbachia, Ian Nunney, Daniel J. Page, Hannah A. Barton, Leena K. Patel, Georgia N. Thomason, Stephan L. Green, Kieran F.J. Lewis, Ketan Dhatariya
  Clinical Therapeutics.2024; 46(2): e59.     CrossRef
• Incidence and Characteristics of the Hyperosmolar Hyperglycemic State: A Danish Cohort Study
  Emilie V. Rosager, Amalia Lærke K. Heltø, Cathrine U. Fox Maule, Lennart Friis-Hansen, Janne Petersen, Finn E. Nielsen, Steen B. Haugaard, Rasmus Gregersen
  Diabetes Care.2024; 47(2): 272.     CrossRef
• Cortisol levels across the lifespan in common marmosets (Callithrix jacchus)
  Matthew Lopez, Amaya Seidl, Kimberley A. Phillips
  American Journal of Primatology.2024;[Epub]     CrossRef
• Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case
  Maria I. Kaleda, Irina P. Nikishina, Alesya V. Firsa
  Current Pediatrics.2024; 22(6): 546.     CrossRef
• Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study
  Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang
  SAGE Open Medicine.2024;[Epub]     CrossRef
• Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus
  Andrew I. Spitzer, Helena W. Rodbard, Sheikh Usman Iqbal, Masato Nakazawa, Mary DiGiorgi, Roy Winston
  The Journal of Arthroplasty.2024; 39(9): S218.     CrossRef
• Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature
  N. T. Vatutin, E. V. Sklyannaya, V. V. Gribov
  Oncohematology.2024; 19(2): 118.     CrossRef
• The safety and use of perioperative dexamethasone in the perioperative management of primary sporadic supratentorial meningiomas
  Felix Arlt, Alim Emre Basaran, Markus Vogel, Martin Vychopen, Clemens Seidel, Alonso Barrantes-Freer, Erdem Güresir, Johannes Wach
  Frontiers in Oncology.2024;[Epub]     CrossRef
• The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial
  Philip Ambery, Grzegorz Zajac, Joachim Almquist, Susanne Prothon, Carol Astbury, Mary N. Brown, Szilard Nemes, Joselyne Nsabimana, Karl Edman, Lisa Öberg, Matti Lepistö, Goran Edenro, Inken Dillmann, Suman Mitra, Graham Belfield, Christina Keen, Tim Heise
  British Journal of Clinical Pharmacology.2024; 90(8): 1921.     CrossRef
• Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone
  Xingxing He, Guangchen Duan, Jingyi Lu, Yaxin Wang, Jinghao Cai, Yiqing Tong, Wei Wu, Xiaojing Ma, Qiming Feng, Jian Zhou
  Endocrine.2024; 86(2): 556.     CrossRef
• DISFUNÇÕES RESPIRATÓRIAS FELINAS
  Felipe Gaia de Sousa, Juliana Uchôa Ribeiro, Suzane Lilian Beier, Myrian Kátia Iser Teixeira
  Veterinária e Zootecnia.2024; 31: 1.     CrossRef
• Letter to the Editor From Hao and Xue: “Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”
  Lu Hao, Jisu Xue
  The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
• Review Artikel: Pengaruh Glukokortioid Terhadap Glukosa Darah Pasien Diabetes Melitus Tipe 2
  Novia Ariani Dewi, Arina Titami
  Jurnal Farmasi SYIFA.2024; 2(2): 68.     CrossRef
• Diabetic ketoacidosis in a patient with type 2 diabetes induced by multiple triggers: a case report and implications for clinical practice
  Konstantinos Kitsios, Christina‐Maria Trakatelli
  Practical Diabetes.2024; 41(3): 27.     CrossRef
• Endocrine Disorders and Peripheral Arterial Disease – A Series of Reviews Cushing Syndrome-Cortisol Excess
  Poredoš P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Bajuk Studen K, Šabović M, Ježovnik MK
  Current Vascular Pharmacology.2024; 22(4): 236.     CrossRef
• Megesterol acetate as an overlooked cause of hyperglycemia in end-stage renal disease: A case of polypharmacy
  John Aurora, Theresa Zheng, Julieta Rossi Fortunati, Feyza Erenler
  Journal of the American Pharmacists Association.2024; 64(6): 102248.     CrossRef
• Corticothérapie : une nécessaire pluridisciplinarité au service du patient ?
  Caroline Samhani, Sandra Tonnette
  Soins.2024; 69(890): 52.     CrossRef
• The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study
  Dominik J. Ose, Emmanuel Adediran, Bayarmaa Mark, Krista Ocier, William A. Dunson JR, Cindy Turner, Belinda Taylor, Kim Svoboda, Andrew R. Post, Jennifer Leiser, Howard Colman, Cornelia M. Ulrich, Mia Hashibe
  Cancer Medicine.2024;[Epub]     CrossRef
• Management of Glucocorticoid-Induced Hyperglycemia in Cancer Patients: A Feasibility Study
  Jenny Wright, Theresa Nielsen, Samantha Burns, Nicole Weekes, Anisha Pradhan, Judeil Krlan Teus, Gemma McErlean
  Clinical Nursing Research.2024;[Epub]     CrossRef
• Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions
  Liudmila V. Spirina, Vladimir N. Masunov, Denis A. Dyakov, Olga E. Akbasheva, Amina Y. Kebekbayeva, Igor Yu. Shuvalov, Nadezhda V. Masunova, Irina V. Kovaleva, Yumzhana Dagbaeva
  Indian Journal of Clinical Biochemistry.2023; 38(4): 437.     CrossRef
• Mouse Pancreatic Peptide Hormones Probed at the Sub-Single-Islet Level: The Effects of Acute Corticosterone Treatment
  Aleksandra Antevska, Connor C. Long, Samuel D. Dupuy, J. Jason Collier, Michael D. Karlstad, Thanh D. Do
  Journal of Proteome Research.2023; 22(1): 235.     CrossRef
• Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know
  Robert van Wilpe, Abraham H. Hulst, Sarah.E. Siegelaar, J. Hans DeVries, Benedikt Preckel, Jeroen Hermanides
  Journal of Clinical Anesthesia.2023; 84: 111012.     CrossRef
• The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis
  Naomi J. Patel, Veronica Tozzo, John M. Higgins, John H. Stone
  Arthritis & Rheumatology.2023; 75(4): 586.     CrossRef
• Characterization, evolution and risk factors of diabetes and prediabetes in a pediatric cohort of renal and liver transplant recipients
  Sophie Welsch, Virginie Mailleux, Priscilla le Hardy de Beaulieu, Nadejda Ranguelov, Nathalie Godefroid, Annie Robert, Xavier Stephenne, Isabelle Scheers, Raymond Reding, Etienne M. Sokal, Philippe A. Lysy
  Frontiers in Pediatrics.2023;[Epub]     CrossRef
• The safety of perioperative dexamethasone with antiemetic dosage in surgical patients with diabetes mellitus: a systematic review and meta-analysis
  Qian-Yun Pang, Jing-Yun Wang, Xiao-Long Liang, Yan Jiang, Hong-Liang Liu
  Perioperative Medicine.2023;[Epub]     CrossRef
• Link between Blood Cell-Associated Inflammatory Indices and Chemotherapy-Induced Hyperglycemia in Women Affected with Breast Cancer: Clinical Studies
  Krishna Prasad, Suresh Rao, Sanath Kumar Hegde, Thomas George, Rhea Katherine D'souza, Sucharitha Suresh, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2023; 12(02): 118.     CrossRef
• Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
  Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer
  Journal of Clinical Medicine.2023; 12(5): 1906.     CrossRef
• Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats
  Priscila L. Zimath, Milena S. Almeida, Maciel A. Bruxel, Alex Rafacho
  Biochemical Pharmacology.2023; 210: 115486.     CrossRef
• Regeneration of an infected skin wound under conditions of experimental steroid hyperglycemia
  L. A. Balykova, V. I. Inchina, T. V. Tarasova, D. A. Khaydar, L. M. Mosina, I. V. Saushev, A. V. Kuchuk, A. Mutvakel, I. V. Begoulov, R. S. Tarasov, P. V. Ageev, D. S. Ovchenkov
  Research and Practical Medicine Journal.2023; 10(1): 90.     CrossRef
• Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
  Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
  International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
• Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
  Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
  Endocrinology and Metabolism.2023; 38(2): 245.     CrossRef
• Zein nanoparticles as oral carrier for mometasone furoate delivery
  Priscila Zimath, Soraia Pinto, Sofia Dias, Alex Rafacho, Bruno Sarmento
  Drug Delivery and Translational Research.2023; 13(11): 2948.     CrossRef
• Impact of Diabetes in COVID-19 Associated Mucormycosis and its Management: A Non-Systematic Literature Review
  Muhammed Rashid, Asha K. Rajan, Girish Thunga, Vishal Shanbhag, Sreedharan Nair
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
  Abdulla Ahmed, Kriss Kania, Hebba Abdul Rahim, Salaheldin Ahmed, Göran Rådegran
  ESC Heart Failure.2023; 10(4): 2427.     CrossRef
• PartII: Interactive case:Drug‐inducedendocrine disorders
  Amy C. Donihi
  JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2023; 6(6): 663.     CrossRef
• Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
  Riccardo Pofi, Giorgio Caratti, David W Ray, Jeremy W Tomlinson
  Endocrine Reviews.2023; 44(6): 975.     CrossRef
• Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
  Yu-Jih Su, Hui-Ming Chen, Tien-Ming Chan, Tien-Tsai Cheng, Shan-Fu Yu, Jia-Feng Chen, Chun-Yu Lin, Chung-Yuan Hsu
  RMD Open.2023; 9(3): e003045.     CrossRef
• The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
  Vasileios Giannopapas, Lina Palaiodimou, Dimitrios Kitsos, Georgia Papagiannopoulou, Konstantina Stavrogianni, Athanasios Chasiotis, Maria Kosmidou, John S. Tzartos, George P. Paraskevas, Daphne Bakalidou, Georgios Tsivgoulis, Sotirios Giannopoulos
  Journal of Clinical Medicine.2023; 12(15): 4948.     CrossRef
• Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities
  Mihaela Simona Popoviciu, Lorena Paduraru, Raluca Marinela Nutas, Alexandra Maria Ujoc, Galal Yahya, Kamel Metwally, Simona Cavalu
  International Journal of Molecular Sciences.2023; 24(16): 12676.     CrossRef
• Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
  Krishna Prasad, Sanath Hegde, Suresh Rao, Rhea Katherine D'souza, Thomas George, Manjeshwar Shrinath Baliga, Sucharitha Suresh
  South Asian Journal of Cancer.2023;[Epub]     CrossRef
• The inverse association between DNA gaps and HbA1c levels in type 2 diabetes mellitus
  Jirapan Thongsroy, Apiwat Mutirangura
  Scientific Reports.2023;[Epub]     CrossRef
• Corticosteroids for COVID-19: worth it or not?
  Fariya Akter, Yusha Araf, Mohammad Jakir Hosen
  Molecular Biology Reports.2022; 49(1): 567.     CrossRef
• Evidence-Based Management of Steroid-Induced Hyperglycemia in the Inpatient Setting
  Lauren Longaker, Jennifer N. Clements
  ADCES in Practice.2022; 10(1): 40.     CrossRef
• Is Methylprednisolone Acetate-Related Insulin Resistance Preventable in Cats?
  Karine Marchioro Leal, Mariana Barcelos Rocha, Fernanda Venzon Varela, Luana Rodrigues, Priscila Viau Furtado, Fernanda Vieira Amorim da Costa, Álan Gomes Pöppl
  Topics in Companion Animal Medicine.2022; 49: 100648.     CrossRef
• Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
  Shruti Mohan, Ryan A. Lafferty, Peter R. Flatt, R. Charlotte Moffett, Nigel Irwin
  Peptides.2022; 152: 170772.     CrossRef
• Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations
  Thiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza, Bruno Halpern
  Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
• When therapeutic drugs lead to diabetes
  Bruno Fève, André J. Scheen
  Diabetologia.2022; 65(5): 751.     CrossRef
• Nutrition implications of intrinsic restrictive lung disease
  Sylvia Rinaldi, Christine Balsillie, Cassandra Truchon, Awatif AL‐Mubarak, Marco Mura, Janet Madill
  Nutrition in Clinical Practice.2022; 37(2): 239.     CrossRef
• Coinfection by Aspergillus and Mucoraceae Species in Two Cases of Acute Rhinosinusitis as a Complication of COVID-19
  Payam Tabarsi, Somayeh Sharifynia, Mihan Pourabdollah Toutkaboni, Zahra Abtahian, Mohammad Rahdar, Arefeh Sadat Mirahmadian, Atousa Hakamifard, Simone Cesaro
  Case Reports in Medicine.2022; 2022: 1.     CrossRef
• Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
  Vasileios Angelis, Stephen R. D. Johnston, Amin Ardestani, Kathrin Maedler
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature
  Victor O. Ukwenya, Sunday A. Adelakun, Temiloluwa A. Fuwape, Ayotunde S. Adeagbo
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
  Rahul Gupta
  Bulletin of the National Research Centre.2022;[Epub]     CrossRef
• Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon
  Fei Peng, Xin Li, Fang Xiao, Ruxing Zhao, Zheng Sun
  Trends in Neurosciences.2022; 45(6): 471.     CrossRef
• 3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress
  Yi Tan, Lingchao Miao, Jianbo Xiao, Wai San Cheang
  Current Issues in Molecular Biology.2022; 44(5): 2175.     CrossRef
• Management of Glucocorticoid-Induced Hyperglycemia
  Parag Shah, Sanjay Kalra, Yogesh Yadav, Nilakshi Deka, Tejal Lathia, Jubbin Jagan Jacob, Sunil Kumar Kota, Saptarshi Bhattacharya, Sharvil S Gadve, KAV Subramanium, Joe George, Vageesh Iyer, Sujit Chandratreya, Pankaj Kumar Aggrawal, Shailendra Kumar Sing
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1577.     CrossRef
• Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
  Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Alexandre Barbosa Câmara de Souza, Juliana Pereira, Ana Oliveira Hoff, Marcia Nery
  einstein (São Paulo).2022;[Epub]     CrossRef
• Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
  Rohit Sharma, Praveen Kumar, Abdur Rauf, Ashun Chaudhary, Pradeep Kumar Prajapati, Talha Bin Emran, Clara Mariana Gonçalves Lima, Carlos Adam Conte-Junior
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• Black pepper oil (Piper nigrum L.) mitigates dexamethasone induced pancreatic damage via modulation of oxidative and nitrosative stress
  Mona F. Mahmoud, Asmaa M. Elmaghraby, Noura Ali, Islam Mostafa, Assem M. El-Shazly, Mohamed A.O. Abdelfattah, Mansour Sobeh
  Biomedicine & Pharmacotherapy.2022; 153: 113456.     CrossRef
• Various Coated Barrier Membranes for Better Guided Bone Regeneration: A Review
  Ji-Youn Kim, Jun-Beom Park
  Coatings.2022; 12(8): 1059.     CrossRef
• RETROSPECTIVE STUDY ON GLYCAEMIC CONTROL OF THE MIDDLE-AGED PATIENTS RECEIVING STEROID THERAPY IN COVID ICU
  Sayantan Dutta, Sumanta Ghosh Maulik, Jisnu Nayak
  PARIPEX INDIAN JOURNAL OF RESEARCH.2022; : 1.     CrossRef
• Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
  Joachim Baech, Marianne Tang Severinsen, Andreas K. Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian B. Poulsen, Peter Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström
  Blood Advances.2022; 6(15): 4427.     CrossRef
• Diabètes pharmaco-induits : quatre classes médicamenteuses au cœur de notre pratique clinique
  André J. Scheen, Bruno Fève
  Médecine des Maladies Métaboliques.2022; 16(7): 627.     CrossRef
• Dexamethasone-Induced Derangement in Some Liver Function Parameters
  Timothy Danboyi, Abdulazeez Jimoh, Evelyn Hassan-Danboyi, Abdul Wahab Alhassan, Augustine Banlibo Dubo
  Nigerian Journal of Experimental and Clinical Biosciences.2022; 10(3): 74.     CrossRef
• Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
  Noemí Villén, Albert Roso-Llorach, Carlos Gallego-Moll, Marc Danes-Castells, Sergio Fernández-Bertolin, Amelia Troncoso-Mariño, Monica Monteagudo, Ester Amado, Concepción Violán
  Geriatrics.2022; 7(6): 141.     CrossRef
• Increased risk of type 2 diabetes in patients with systemic lupus erythematosus: A nationwide cohort study in Taiwan
  Yeong-Jang Lin, Chih-Chiang Chien, Chung-Han Ho, Hung-An Chen, Chao-Yu Chen
  Medicine.2022; 101(51): e32520.     CrossRef
• Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety
  Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D. Poole, Daniela Baracaldo-Santamaría, Claudia M. Tellez Freitas
  Medicina.2022; 59(1): 56.     CrossRef
• Effect of Ficus lacor Buch. Ham. Fruit Extract on Dexamethasone Induced Insulin Resistant Rats
  V. S. Mule, N. S. Naikwade
  Research Journal of Pharmacy and Technology.2022; : 5559.     CrossRef
• Prednisolone-induced diabetes mellitus in the cat: a historical cohort
  Sivert Nerhagen, Hanne L Moberg, Gudrun S Boge, Barbara Glanemann
  Journal of Feline Medicine and Surgery.2021; 23(2): 175.     CrossRef
• Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
  Mattia Quattrocelli, Aaron S. Zelikovich, Isabella M. Salamone, Julie A. Fischer, Elizabeth M. McNally
  Journal of Neuromuscular Diseases.2021; 8(1): 39.     CrossRef
• A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
  Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
  Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
• Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases
  Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos
  Pharmacological Reports.2021; 73(3): 796.     CrossRef
• Epigenetics in blood–brain barrier disruption
  Stephanie A. Ihezie, Iny Elizebeth Mathew, Devin W. McBride, Ari Dienel, Spiros L. Blackburn, Peeyush Kumar Thankamani Pandit
  Fluids and Barriers of the CNS.2021;[Epub]     CrossRef
• Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes
  Catherine Li, Patricia Krause, Gretchen Stern
  Endocrine.2021; 73(2): 476.     CrossRef
• Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women
  Wojciech Krzyzanski, Mark A. Milad, Alan H. Jobe, Thomas Peppard, Robert R. Bies, William J. Jusko
  Journal of Pharmacokinetics and Pharmacodynamics.2021; 48(3): 411.     CrossRef
• Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
  Tamarra James-Todd, Lisa Connolly, Emma V. Preston, Marlee R. Quinn, Monika Plotan, Yuling Xie, Bharathi Gandi, Shruthi Mahalingaiah
  Journal of Exposure Science & Environmental Epidemiology.2021; 31(3): 476.     CrossRef
• New‐onset diabetes in “long COVID”
  Thirunavukkarasu Sathish, Mary Chandrika Anton, Tharsan Sivakumar
  Journal of Diabetes.2021; 13(8): 693.     CrossRef
• Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages
  Yufei Xie, Jiajun Xie, Annemarie H. Meijer, Marcel J. M. Schaaf
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes
  Anthony Aylward, Mei-Lin Okino, Paola Benaglio, Joshua Chiou, Elisha Beebe, Jose Andres Padilla, Sharlene Diep, Kyle J. Gaulton, Michael L. Stitzel
  PLOS Genetics.2021; 17(5): e1009531.     CrossRef
• A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
  Felix Aberer, Daniel A. Hochfellner, Harald Sourij, Julia K. Mader
  Journal of Clinical Medicine.2021; 10(10): 2154.     CrossRef
• Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
  Aditya Maulana Perdana Putra, Ratih Pratiwi Sari, Siska Musiam
  Borneo Journal of Pharmacy.2021; 4(2): 84.     CrossRef
• Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
  Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna, Kumar Gaurav
  Endocrine and Metabolic Science.2021; 4: 100102.     CrossRef
• Genome-Wide Differential Methylation Profiles from Two Terpene-Rich Medicinal Plant Extracts Administered in Osteoarthritis Rats
  Younhee Shin, Sathiyamoorthy Subramaniyam, Jin-Mi Chun, Ji-Hyeon Jeon, Ji-Man Hong, Hojin Jung, Boseok Seong, Chul Kim
  Plants.2021; 10(6): 1132.     CrossRef
• Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
  Erika Harno, Charlotte Sefton, Jonathan R. Wray, Tiffany-Jayne Allen, Alison Davies, Anthony P. Coll, Anne White
  Scientific Reports.2021;[Epub]     CrossRef
• Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment
  Filippo Egalini, Mirko Parasiliti Caprino, Giulia Gaggero, Vincenzo Cappiello, Jacopo Giannelli, Ruth Rossetto Giaccherino, Loredana Pagano, Roberta Giordano
  Endocrines.2021; 2(3): 171.     CrossRef
• Current cancer therapies and their influence on glucose control
  Carly Yim, Kerry Mansell, Nassrein Hussein, Terra Arnason
  World Journal of Diabetes.2021; 12(7): 1010.     CrossRef
• Immune‐checkpoint inhibitor‐associated diabetes compared to other diabetes types ‐ A prospective, matched control study
  Sascha R. Tittel, Katharina Laubner, Sebastian M. Schmid, Stefan Kress, Sigrun Merger, Wolfram Karges, Frank J. Wosch, Marcus Altmeier, Marianne Pavel, Reinhard W. Holl
  Journal of Diabetes.2021; 13(12): 1007.     CrossRef
• Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
  Hariprasath Prakash, Anna Skiada, Raees Ahmad Paul, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy
  Journal of Fungi.2021; 7(8): 616.     CrossRef
• Antioxidant Effects of L-citrulline Supplementation in High-fat Diet- and Dexamethasone-induced Type-2 Diabetes Mellitus in Wistar Rats (Rattus norvegicus)
  Evelyn Hassan-Danboyi, Abdulazeez Jimoh, Abdulwahab Alhassan, Timothy Danboyi, Kabir Ahmed Mohammed, Augustine Banlibo Dubo, Jamilu Haruna, Bulus Billy Yakubu
  Nigerian Journal of Experimental and Clinical Biosciences.2021; 9(2): 95.     CrossRef
• ASSESSMENT OF THE POSSIBLE CAUSES OF DIABETES MELLITUS DEVELOPED IN PATIENTS POST COVID-19 TREATMENT IN A TERTIARY CARE HOSPITAL
  KHUJITH RAJUENI, RUTUJA AMBEKAR, HITENDRAPAL SOLANKI, ABDULRAHAMAN ABUBAKAR MOMIN, SUNITA PAWAR
  International Journal of Pharmacy and Pharmaceutical Sciences.2021; : 11.     CrossRef
• Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion
  Brandon J. Kennedy, Ashley M. Lato, Alexander R. Fisch, Susan J. Burke, Justin K. Kirkland, Carson W. Prevatte, Lee E. Dunlap, Russell T. Smith, Konstantinos D. Vogiatzis, J. Jason Collier, Shawn R. Campagna
  ACS Medicinal Chemistry Letters.2021; 12(10): 1568.     CrossRef
• Diabetes in COVID-19 patients: challenges and possible management strategies
  Riyan Al Islam Reshad, Sumaiya Hafiz Riana, Mohammad Al-baruni Chowdhury, Abu Tayab Moin, Faruque Miah, Bishajit Sarkar, Nurnabi Azad Jewel
  The Egyptian Journal of Bronchology.2021;[Epub]     CrossRef
• Excess Body Mass—A Factor Leading to the Deterioration of COVID-19 and Its Complications—A Narrative Review
  Weronika Gryczyńska, Nikita Litvinov, Bezawit Bitew, Zuzanna Bartosz, Weronika Kośmider, Paweł Bogdański, Damian Skrypnik
  Viruses.2021; 13(12): 2427.     CrossRef
• Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation
  Jagriti Upadhyay, Nitin Trivedi, Amos Lal
  Lung.2020; 198(3): 525.     CrossRef
• Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
  Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou
  Toxicology Letters.2020; 320: 19.     CrossRef
• Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
  Mohamad Isam Saeed, Josefin Eklöf, Imane Achir, Pradeesh Sivapalan, Howraman Meteran, Anders Løkke, Tor Biering‐Sørensen, Filip Krag Knop, Jens‐Ulrik Stæhr Jensen
  Diabetes, Obesity and Metabolism.2020; 22(8): 1348.     CrossRef

• Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

  
  Andreja Marić, Tanja Miličević, Jelena Vučak Lončar, Davor Galušić, Maja Radman
  International Journal of General Medicine.2020; Volume 13: 131.     CrossRef
• Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers
  Lucy A Ochola, David G Nyamu, Eric M Guantai, Irene W Weru
  Journal of Oncology Pharmacy Practice.2020; 26(4): 823.     CrossRef
• Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with
  Carina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, Tomas Møller Christensen, Thomas Peter Almdal, Ole Snorgaard, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
  BMC Endocrine Disorders.2020;[Epub]     CrossRef
• Implementation of a Weight-Based Protocol for the Management of Steroid-Induced Hyperglycemia
  Alyson K. Myers, Mahmuda Khan, Sebastian Choi, Patricia Garnica, Guillaume Stoffels, Amanda Lin
  American Journal of Therapeutics.2020; 27(4): e392.     CrossRef
• The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study
  Qingqing Zhao, Jinxin Zhou, Yu Pan, Huijun Ju, Liying Zhu, Yang Liu, Yifan Zhang
  Acta Diabetologica.2020; 57(11): 1383.     CrossRef
• Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
  Jianhua Wu, Sarah L Mackie, Mar Pujades-Rodriguez
  BMJ Open Diabetes Research & Care.2020; 8(1): e001220.     CrossRef
• Diabète et corticoïdes : nouveautés et aspects pratiques
  M. Bastin, F. Andreelli
  La Revue de Médecine Interne.2020; 41(9): 607.     CrossRef
• Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
  Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan, Gabriela H. Telo
  Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
• Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes
  Ebenezer Nyenwe, Deirdre James, Jim Wan, Sam Dagogo-Jack
  Journal of the Endocrine Society.2020;[Epub]     CrossRef
• Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
  Neele Delfs, Tristan Struja, Sandra Gafner, Thaddaeus Muri, Ciril Baechli, Philipp Schuetz, Beat Mueller, Claudine Angela Blum
  Journal of Clinical Medicine.2020; 9(12): 4079.     CrossRef
• Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
  Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2020; 09(03): 130.     CrossRef
• Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study
  Imadeldin Elfaki, Rashid Mir, Faisel Mohammed Abu-Duhier, Chandan Kumar Jha, Adel Ibrahim Ahmad Al-Alawy, Abdullatif Taha Babakr, Salem Abd El-Hadi Habib
  Current Drug Metabolism.2020; 21(14): 1152.     CrossRef
• What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?
  Güven Barış Cansu, Döndü Üsküdar Cansu, Bengür Taşkıran, Şule Yaşar Bilge, Muzaffer Bilgin, Cengiz Korkmaz
  Clinical Biochemistry.2019; 67: 33.     CrossRef
• Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
  Yohei Asada, Takeshi Takayanagi, Tsukasa Kawakami, Eisuke Tomatsu, Atsushi Masuda, Yasumasa Yoshino, Sahoko Sekiguchi-Ueda, Megumi Shibata, Tomihiko Ide, Hajime Niimi, Eishin Yaoita, Yusuke Seino, Yoshihisa Sugimura, Atsushi Suzuki
  International Journal of Endocrinology.2019; 2019: 1.     CrossRef
• Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
  Pragyi Shrestha, Bart van de Sluis, Robin P.F. Dullaart, Jacob van den Born
  Cellular Signalling.2019; 55: 53.     CrossRef
• Understanding the burden of refractory myasthenia gravis
  Christiane Schneider-Gold, Tim Hagenacker, Nico Melzer, Tobias Ruck
  Therapeutic Advances in Neurological Disorders.2019;[Epub]     CrossRef
• Drug-induced diabetes type 2: In silico study involving class B GPCRs
  Dorota Latek, Ewelina Rutkowska, Szymon Niewieczerzal, Judyta Cielecka-Piontek, Arun Shukla
  PLOS ONE.2019; 14(1): e0208892.     CrossRef
• Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study
  Toshiyuki Takahashi, Takayuki Okamoto, Yasuyuki Sato, Takeshi Yamazaki, Asako Hayashi, Hayato Aoyagi, Michihiko Ueno, Norio Kobayashi, Kimiaki Uetake, Masanori Nakanishi, Tadashi Ariga
  Pediatric Nephrology.2019; 34(1): 87.     CrossRef
• Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
  Milos Tatalovic, Roger Lehmann, Marcus Cheetham, Albina Nowak, Edouard Battegay, Silvana K Rampini
  BMJ Open.2019; 9(5): e028914.     CrossRef
• The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis
  Panteleimon Pantelidis, Parmenion P. Tsitsopoulos, Eleni Pappa, Elpida Theologou, Nikolaos Karanikolas, Christos Drosos, Christos Tsonidis
  Clinical Neurology and Neurosurgery.2019; 184: 105450.     CrossRef
• Impact of glucocorticoid treatment before pregnancy on glucose homeostasis of offspring exposed to glucocorticoid in adult life
  Flávia Natividade da Silva, Henver Simionato Brunetta, Maciel Alencar Bruxel, Felipe Azevedo Gomes, Alex Rafacho
  Life Sciences.2019; 237: 116913.     CrossRef
• One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice
  Susan J. Burke, Heidi M. Batdorf, Tai-Yu Huang, Joseph W. Jackson, Katarina A. Jones, Thomas M. Martin, Kristen E. Rohli, Michael D. Karlstad, Tim E. Sparer, David H. Burk, Shawn R. Campagna, Robert C. Noland, Paul L. Soto, J. Jason Collier
  The Journal of Steroid Biochemistry and Molecular Biology.2019; 195: 105468.     CrossRef
• Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital
  Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo
  Annals of Intensive Care.2019;[Epub]     CrossRef
• Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
  Amy Hiestand, James Flory, Ritika Chitkara
  Current Diabetes Reports.2019;[Epub]     CrossRef
• Corticothérapie prolongée chez une personne âgée et diabète
  J.L. Schlienger
  Médecine des Maladies Métaboliques.2018; 12(7): 599.     CrossRef
• Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver
  Fatemeh Hassani-Nezhad-Gashti, Jaana Rysä, Outi Kummu, Juha Näpänkangas, Marcin Buler, Mikko Karpale, Janne Hukkanen, Jukka Hakkola
  Biochemical Pharmacology.2018; 148: 253.     CrossRef
• Diabetes Mellitus Secondary to Cushing’s Disease
  Mattia Barbot, Filippo Ceccato, Carla Scaroni
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
  Anjana Radhakutty, Morton G Burt
  European Journal of Endocrinology.2018; 179(4): R207.     CrossRef
• Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study
  Ala Keyany, Johannes T.H. Nielen, Patrick C. Souverein, Frank de Vries, Bart van den Bemt
  Diabetes Research and Clinical Practice.2018; 139: 100.     CrossRef
• Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion
  Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Shizuka Kurauchi, Shigeyuki Nakaji
  Scientific Reports.2017;[Epub]     CrossRef

Impaired awareness of hypoglycemia has been found to be prevalent in 20% to 40% of people with type 1 diabetes. If a similar prevalence exists in Koreans with type 1 diabetes, at a minimum, thousands of people with type 1 diabetes suffer at least one unpredicted episode of severe hypoglycemia per year in Korea. For patients with problematic hypoglycemia, an evidence-based stepwise approach was suggested in 2015. The first step is structured education regarding multiple daily injections of an insulin analog, and the second step is adding a technological intervention, such as continuous subcutaneous insulin infusion or real-time continuous glucose monitoring. The next step is a sensor-augmented pump, preferably with a low glucose suspension feature or very frequent contact, and the final step is islet or pancreas transplantation. In Korea, however, none of these treatments are reimbursed by the National Health Insurance, and thus have not been widely implemented. The low prevalence of type 1 diabetes means that Korean physicians are relatively unfamiliar with the new technologies in this field. Therefore, the roles of new technologies and pancreas or islet transplantation in the treatment of problematic hypoglycemia need to be defined in the current clinical setting of Korea.

Citations

Citations to this article as recorded by  

• Protective and risk factors of impaired awareness of hypoglycemia in patients with type 1 diabetes: a cross-sectional analysis of baseline data from the PR-IAH study
  Naoki Sakane, Ken Kato, Sonyun Hata, Erika Nishimura, Rika Araki, Kunichi kouyama, Masako Hatao, Yuka Matoba, Yuichi Matsushita, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata, Fei Ling Wu
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus
  Jiyun Park, Nammi Park, Sangjin Han, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Woo Je Lee, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2022; 46(6): 941.     CrossRef
• Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
  Vadim V. Klimontov
  Diabetes mellitus.2019; 21(6): 513.     CrossRef

Recently, cardiovascular morbidity and mortality have been continuously reduced in people with diabetes through the intensive management of multiple risk factors. However, contrary to this trend, the prevalence and clinical significance of neurodegenerative disorders are steadily increasing. In previous studies, diabetes mellitus has been found to play an important role in increasing the risk of dementia and cognitive dysfunction through various mechanisms. In particular, hypoglycemia is a frequent clinical situation in the strict management of diabetes and is well known as an important factor that directly affects the risk of dementia and cognitive impairment. This article describes the occurrence of hypoglycemia in patients with diabetes, and summarizes the resultant risks of dementia and cognitive dysfunction.

Citations

Citations to this article as recorded by  

• Inhibitor of DNA Binding Protein 3 (ID3) and Nuclear Respiratory Factor 1 (NRF1) Mediated Transcriptional Gene Signatures are Associated with the Severity of Cerebral Amyloid Angiopathy
  Christian Michael Perez, Zhenghua Gong, Changwon Yoo, Deodutta Roy, Alok Deoraj, Quentin Felty
  Molecular Neurobiology.2024; 61(2): 835.     CrossRef
• Correlates of Self-Reported Executive Function Impairment Among Medicaid Beneficiaries With Type 2 Diabetes
  David Von Nordheim, Cynthia Herrick, Niko Verdecias, Rachel Garg, Matthew W. Kreuter, Amy McQueen
  Diabetes Spectrum.2024; 37(4): 369.     CrossRef
• Continuous glucose monitoring assessment in patients suffering from anorexia nervosa reveals chronic prolonged mild hypoglycemia all over the nycthemeron
  Natacha Germain, Clara Devin Genteuil, Gwenaëlle Belleton, Trecy Lopes Da Silva, Chloé Exbrayat, Fabien Degas, Amira Hammour, Aurélia Gay, Baptiste Ravey, Catherine Massoubre, Bogdan Galusca
  European Eating Disorders Review.2023; 31(3): 402.     CrossRef
• Protective Potential of β-Hydroxybutyrate against Glucose-Deprivation-Induced Neurotoxicity Involving the Modulation of Autophagic Flux and the Monomeric Aβ Level in Neuro-2a Cells
  Yi-Fen Chiang, Ngan Thi Kim Nguyen, Shih-Min Hsia, Hsin-Yuan Chen, Shyh-Hsiang Lin, Ching-I Lin
  Biomedicines.2023; 11(3): 698.     CrossRef
• The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms
  Konstantinos N Fountoulakis, Stephen M Stahl
  Journal of Psychopharmacology.2022; 36(4): 428.     CrossRef
• Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial
  Nicole Jacqueline Jensen, Helena Zander Wodschow, Mads Juul Skytte, Amirsalar Samkani, Arne Astrup, Jan Frystyk, Bolette Hartmann, Jens Juul Holst, Thomas Meinert Larsen, Sten Madsbad, Faidon Magkos, Kamilla Woznica Miskowiak, Steen Bendix Haugaard, Thure
  Clinical Nutrition.2022; 41(7): 1605.     CrossRef
• Amyloid $$upbeta$$ (1–42) peptide impairs mitochondrial respiration in primary human brain microvascular endothelial cells: impact of dysglycemia and pre-senescence
  Siva S. V. P. Sakamuri, Venkata N. Sure, Xiaoying Wang, Gregory Bix, Vivian A. Fonseca, Ricardo Mostany, Prasad V. G. Katakam
  GeroScience.2022; 44(6): 2721.     CrossRef
• Analysis of patients with dementia: Use of computer tomographic and vascular risk
  Mauricio Sánchez-Barajas, Tirtha Prasad-Mukhopadhyay, José María De la Roca-Chiapas, Teodoro Córdova-Fraga
  Revista de Fisioterapia y Tecnología Médica.2022; : 1.     CrossRef
• The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia
  Konstantinos N. Fountoulakis, Hans-Jurgen Moeller, Siegfried Kasper, Carol Tamminga, Shigeto Yamawaki, Rene Kahn, Rajiv Tandon, Christoph U. Correll, Afzal Javed
  CNS Spectrums.2021; 26(6): 562.     CrossRef
• Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control
  John Anderson, Luigi Meneghini, Debbie Hinnen, Jasvinder Gill, Mathieu Coudert, Pierre Evenou, Medha Munshi
  Journal of Diabetes and its Complications.2021; 35(4): 107831.     CrossRef
• Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks
  Olga V. Saik, Vadim V. Klimontov
  International Journal of Molecular Sciences.2021; 22(22): 12419.     CrossRef
• Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
  Kuan-Chan Chen, Chi-Hsiang Chung, Chieh-Hua Lu, Nian-Sheng Tzeng, Chien-Hsing Lee, Sheng-Chiang Su, Feng-Chih Kuo, Jhih-Syuan Liu, Chang-Hsun Hsieh, Wu-Chien Chien
  Journal of Clinical Medicine.2020; 9(3): 660.     CrossRef

An adrenal incidentaloma is an adrenal mass found in an imaging study performed for other reasons unrelated to adrenal disease and often accompanied by obesity, diabetes, or hypertension. The prevalence and incidence of adrenal incidentaloma increase with age and are also expected to rise due to the rapid development of imaging technology and frequent imaging studies. The Korean Endocrine Society is promoting an appropriate practice guideline to meet the rising incidence of adrenal incidentaloma, in cooperation with the Korean Adrenal Gland and Endocrine Hypertension Study Group. In this paper, we discuss important core issues in managing the patients with adrenal incidentaloma. After evaluating core proposition, we propose the most critical 20 recommendations from the initially organized 47 recommendations by Delphi technique.

Citations

Citations to this article as recorded by  

• Diagnosis and management of adrenal incidentaloma: use of clinical judgment and evidence in dialog with the patient
  Yusaku Yoshida, Kiyomi Horiuchi, Michio Otsuki, Takahiro Okamoto
  Surgery Today.2024; 54(12): 1417.     CrossRef
• The improvement of postoperative blood pressure and associated factors in patients with hormone‐negative adrenal adenoma and hypertension
  Jiaxing Sun, Yingchun Dong, Hanbo Wang, Xudong Guo, Ning Suo, Shangjian Li, Xiangbin Ren, Shaobo Jiang
  Journal of Surgical Oncology.2024; 129(6): 1073.     CrossRef
• Clinical features and treatment options for pediatric adrenal incidentalomas: a retrospective single center study
  Xiaojiang Zhu, Saisai Liu, Yimin Yuan, Nannan Gu, Jintong Sha, Yunfei Guo, Yongji Deng
  BMC Pediatrics.2024;[Epub]     CrossRef
• Mineral metabolism assays and osteoporotic fracture risk evaluation in menopausal population diagnosed with adrenal incidentalomas: a sub-analysis of PRECES study
  Alexandra-Ioana Trandafir, Mihaela Stanciu, Ana Valea, Oana-Claudia Sima, Claudiu Nistor, Mădălina Gabriela Iliescu, Ileana Ciobanu, Florina Ligia Popa, Mara Carsote
  Balneo and PRM Research Journal.2024; 15(Vol.15, no): 692.     CrossRef
• Assessment of the diagnostic efficacy of radiological and functional evaluation of primary adrenal mass and its’ surgical outcomes
  Yash Manharlal Tilala, Sabyasachi Panda, Abhilekh Tripathi, Sachin Sharma, Amiya Shankar Paul, Sanjay Choudhuri, Samir Swain
  Urologia Journal.2024; 91(4): 674.     CrossRef
• Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in South India: A Retrospective Study
  Abhijeet B Jawanjal, Siddarth Sadananda, Nikitha Sriramaneni, Y. P. Ganavi, Pramila Kalra, Chitra Selvan, P. R. Manjunath, Praneethi K. Shetty
  Annals of African Medicine.2024; 23(4): 567.     CrossRef
• Quantitative imaging biomarkers in the assessment of adrenal nodules
  Mariana Yalon, Patrick J. Navin
  Abdominal Radiology.2024;[Epub]     CrossRef
• Clinical and Radiological Features of Atypical Adrenal Masses—A Multicenter Retrospective Study
  Vania Balderrama-Brondani, Ruaa Al-Ward, Katja Kiseljak-Vassiliades, Lauren Fishbein, Danielle Dawes, Oksana Hamidi, Reza Pishdad, Juan Pablo Perdomo Rodriguez, Mohamad Anas Sukkari, Joseph R Grajo, Hans Kumar Ghayee, Sara Bedrose, Roland L Bassett, Amir
  The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
• Characterizing incidental mass lesions in abdominal dual-energy CT compared to conventional contrast-enhanced CT
  Jack Junchi Xu, Peter Sommer Ulriksen, Camilla Wium Bjerrum, Michael Patrick Achiam, Timothy Andrew Resch, Lars Lönn, Kristoffer Lindskov Hansen
  Acta Radiologica.2023; 64(3): 945.     CrossRef
• Metastatic Adrenal PEComa: Case Report and Short Review of the Literature
  Enrico Battistella, Luca Pomba, Marica Mirabella, Michele Gregianin, Antonio Scapinello, Marco Volante, Antonio Toniato
  Medicina.2023; 59(1): 149.     CrossRef
• Surgical management and outcomes of spinal metastasis of malignant adrenal tumor: A retrospective study of six cases and literature review
  Xiangzhi Ni, Jing Wang, Jiashi Cao, Kun Zhang, Shuming Hou, Xing Huang, Yuanjin Song, Xin Gao, Jianru Xiao, Tielong Liu
  Frontiers in Oncology.2023;[Epub]     CrossRef
• An adrenal incidentaloma that had appeared to produce dehydroepiandrosterone-sulfate in excess before immunohistochemical study of the tumor
  Toshihide Yamamoto, Takuma Kimura, Yuki Kubo, Shin-ichi Nakatsuka, Hiromasa Harada, Takashi Suzuki, Hironobu Sasano
  Endocrine Journal.2023; 70(1): 43.     CrossRef
• Mortality Not Increased in Patients With Nonfunctional Adrenal Adenomas: A Matched Cohort Study
  Albin Kjellbom, Ola Lindgren, Malin Danielsson, Henrik Olsen, Magnus Löndahl
  The Journal of Clinical Endocrinology & Metabolism.2023; 108(8): e536.     CrossRef
• Construction of a novel clinical nomogram to predict cancer-specific survival in patients with primary malignant adrenal tumors: a large population-based retrospective study
  Mingzhen Li, Xiaoying Duan, Di You, Linlin Liu
  Frontiers in Medicine.2023;[Epub]     CrossRef
• Primary Aldosteronism Prevalence – An Unfolding Story
  Suranut Charoensri, Adina F. Turcu
  Experimental and Clinical Endocrinology & Diabetes.2023; 131(07/08): 394.     CrossRef
• Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas
  Alexandra-Ioana Trandafir, Mihaela Stanciu, Simona Elena Albu, Vasile Razvan Stoian, Irina Ciofu, Cristian Persu, Claudiu Nistor, Mara Carsote
  Journal of Clinical Medicine.2023; 12(13): 4244.     CrossRef
• Clinical manifestations of functionally autonomous cortisol secretion in patients with adrenal masse
  T. R. Chzhen, T. P. Kiseleva
  Ural Medical Journal.2023; 22(3): 13.     CrossRef
• Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature?
  M. Caputo, T. Daffara, A. Ferrero, M. Romanisio, E. Monti, C. Mele, M. Zavattaro, S. Tricca, A. Siani, A. Clemente, C. Palumbo, S. De Cillà, A. Carriero, A. Volpe, P. Marzullo, G. Aimaretti, F. Prodam
  Journal of Endocrinological Investigation.2023; 47(2): 377.     CrossRef
• Adrenal ganglioneuroma: Features and outcomes of cases series
  Pei Li, Rongchang Zhang, Guang Wang, Jiongming Li
  Asian Journal of Surgery.2023; 46(11): 5272.     CrossRef
• Recent Updates on the Management of Adrenal Incidentalomas
  Seung Shin Park, Jung Hee Kim
  Endocrinology and Metabolism.2023; 38(4): 373.     CrossRef
• Adrenal malakoplakia a rare lesion that mimics a neoplasm
  Orión Erenhú Rodríguez González, Jesus Eduardo Osorio, Edgar Iván Bravo Castro
  Urology Case Reports.2023; 51: 102568.     CrossRef
• LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines
  Jongsung Noh, Chaelin Lee, Jung Hee Kim, Seung Woon Myung, Man Ho Choi
  Journal of Lipid Research.2023; 64(11): 100453.     CrossRef
• Incidentaloma adrenal. Del hallazgo casual al diagnóstico definitivo
  Mercedes Retamal Ortíz, Ana Belén Vicario Parada, Elena Vázquez Jarén
  Actualización en Medicina de Familia.2023;[Epub]     CrossRef
• Can MDCT Enhancement Patterns Be Helpful in Differentiating Secretory from Non-Functional Adrenal Adenoma?
  Svetlana Kocic, Vladimir Vukomanovic, Aleksandar Djukic, Jovica Saponjski, Dusan Saponjski, Vuk Aleksic, Vesna Ignjatovic, Katarina Vuleta Nedic, Vladan Markovic, Radisa Vojinovic
  Medicina.2023; 60(1): 72.     CrossRef
• Computer-assisted Reporting and Decision Support Increases Compliance with Follow-up Imaging and Hormonal Screening of Adrenal Incidentalomas
  Renata R. Almeida, Bernardo C. Bizzo, Ramandeep Singh, Katherine P. Andriole, Tarik K. Alkasab
  Academic Radiology.2022; 29(2): 236.     CrossRef
• Incidental Adrenal Masses: Adherence to Guidelines and Methods to Improve Initial Follow-Up: A Systematic Review
  Timothy Feeney, Andrea Madiedo, Philip E. Knapp, Avneesh Gupta, David McAneny, Frederick Thurston Drake
  Journal of Surgical Research.2022; 269: 18.     CrossRef
• Incidental Adrenal Lesions May Not Always Require Further Imaging Work-up
  Deborah A. Baumgarten
  Radiology.2022; 302(1): 138.     CrossRef
• Adrenal Nodules Detected at Staging CT in Patients with Resectable Gastric Cancers Have a Low Incidence of Malignancy
  Hae Young Kim, Won Chang, Yoon Jin Lee, Ji Hoon Park, Jungheum Cho, Hee Young Na, Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, Young Hoon Kim, Kyoung Ho Lee
  Radiology.2022; 302(1): 129.     CrossRef
• Management of incidental adrenal nodules: a survey of abdominal radiologists conducted by the Society of Abdominal Radiology Disease-Focused Panel on Adrenal Neoplasms
  Michael T. Corwin, Nicola Schieda, Erick M. Remer, Elaine M. Caoili
  Abdominal Radiology.2022; 47(4): 1360.     CrossRef
• Primary hyperaldosteronism: indications for screening
  Novella M. Chikhladze
  Terapevticheskii arkhiv.2022; 94(1): 107.     CrossRef
• Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas
  Jordan A. Higgs, Alyssa P. Quinn, Kevin D. Seely, Zeke Richards, Shad P. Mortensen, Cody S. Crandall, Amanda E. Brooks
  International Journal of Molecular Sciences.2022; 23(8): 4340.     CrossRef
• Can Radiomics Provide Additional Diagnostic Value for Identifying Adrenal Lipid-Poor Adenomas From Non-Adenomas on Unenhanced CT?
  Binhao Zhang, Huangqi Zhang, Xin Li, Shengze Jin, Jiawen Yang, Wenting Pan, Xue Dong, Jin Chen, Wenbin Ji
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Adrenal Surgery in the Era of Multidisciplinary Endocrine Tumor Boards
  Costanza Chiapponi, Daniel Pinto Dos Santos, Milan Janis Michael Hartmann, Matthias Schmidt, Michael Faust, Roger Wahba, Christiane Josephine Bruns, Anne Maria Schultheis, Hakan Alakus
  Hormone and Metabolic Research.2022; 54(05): 294.     CrossRef
• Optimal and novel imaging of the adrenal glands
  Patrick J. Navin, Michael R. Moynagh
  Current Opinion in Endocrinology, Diabetes & Obesity.2022; 29(3): 253.     CrossRef
• Adrenal Tumors in Young Adults: Case Reports and Literature Review
  Małgorzata Zdrojewska, Emilia Mech-Siebieszuk, Renata Świątkowska-Stodulska, Bartosz Regent, Michał Kunc, Łukasz Zdrojewski, Krzysztof Sworczak
  Medicina.2022; 58(6): 746.     CrossRef
• Incidence of malignancy in adrenal nodules detected on staging CTs of patients with potentially resectable colorectal cancer
  Hae Young Kim, Yoon Jin Lee, Won Chang, Ji Hoon Park, Jungheum Cho, Hyeon Jeong Oh, Young Hoon Kim, Kyoung Ho Lee
  European Radiology.2022; 32(12): 8560.     CrossRef
• Appendiceal Incidentalomas: Prevalence, Radiographic Characteristics, Management, and Outcomes
  Adam Kelly, Stacy O’Connor, Diana Kane, Chiang-Ching Huang, Harveshp Mogal
  Annals of Surgical Oncology.2022; 29(13): 8265.     CrossRef
• Laparoscopic large adrenal mass resection: why we should be more careful?
  Mohsen Varyani, Mahmood Parvin, Hamidreza Akbari Gilani
  African Journal of Urology.2022;[Epub]     CrossRef
• Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
  Nadia Sawicka-Gutaj, Hanna Komarowska, Dawid Gruszczyński, Aleksandra Derwich, Anna Klimont, Marek Ruchała
  Journal of Clinical Medicine.2022; 11(19): 5563.     CrossRef
• Application of radiomics in adrenal incidentaloma: a literature review
  Cheng Li, Yan Fu, Xiaoping Yi, Xiao Guan, Longfei Liu, Bihong T. Chen
  Discover Oncology.2022;[Epub]     CrossRef
• Hormone-inactive adrenal tumors in clinician’s practice
  T. R. Chzhen, T. P. Kiseleva
  Perm Medical Journal.2022; 39(5): 48.     CrossRef
• The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism
  Vendela Berndt, Per Dahlqvist, Jennie de Verdier, Henrik Ryberg, Oskar Ragnarsson
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The Role of Intraoperative Indocyanine Green (ICG) and Preoperative 3-Dimensional (3D) Reconstruction in Laparoscopic Adrenalectomy: A Propensity Score-matched Analysis
  Giuseppe Palomba, Vincenza Paola Dinuzzi, Francesca Pegoraro, Roberto Ivan Troisi, Roberto Montalti, Giovanni Domenico De Palma, Giovanni Aprea
  Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2022; 32(6): 643.     CrossRef
• The Etiological Profile of Adrenal Incidentalomas
  Fatima-Zahra Lahmamssi, Loubna Saadaoui, Hayat Aynaou, Houda Salhi, Hanan El Ouahabi
  Cureus.2022;[Epub]     CrossRef
• Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
  Jong Chul Won, Ki-Hyun Baek
  Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
• Conduite à tenir face à un fortuitome surrénalien chez le chien ou le chat
  Diane Pichard, Ghita Benckekroun
  Le Nouveau Praticien Vétérinaire canine & féline.2022; 19(82): 40.     CrossRef
• Laparoscopic transperitoneal adrenalectomy: a comparative study of different techniques for vessel sealing
  Luca Cardinali, Edlira Skrami, Elisa Catani, Flavia Carle, Monica Ortenzi, Andrea Balla, Mario Guerrieri
  Surgical Endoscopy.2021; 35(2): 673.     CrossRef
• Epidemiology and Comorbidity of Adrenal Cushing Syndrome: A Nationwide Cohort Study
  Chang Ho Ahn, Jung Hee Kim, Man Young Park, Sang Wan Kim
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1362.     CrossRef
• Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review
  Marta Araujo-Castro, Pablo Valderrábano, Héctor F. Escobar-Morreale, Felicia A. Hanzu, Gregori Casals
  Endocrine.2021; 72(1): 40.     CrossRef
• A Rare Neoplasm: Primary Adrenal Leiomyosarcoma
  Jack T. Barnett, Christine W. Liaw, Reza Mehrazin
  Urology.2021; 148: e11.     CrossRef
• Adrenal Ganglioneuroma Presenting as an Incidentaloma in an Adolescent Patient
  Sonia G. Sharma, Steven N. Levine, Xin Gu
  AACE Clinical Case Reports.2021; 7(1): 61.     CrossRef
• Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series
  Jeongmin Lee, Jeonghoon Ha, Sang-Kuon Lee, Hye Lim Park, Sung-Hoon Kim, Dong-Jun Lim, Jung Min Lee, Sang-Ah Chang, Moo Il Kang, Min-Hee Kim
  International Journal of General Medicine.2021; Volume 14: 673.     CrossRef
• Best Achievements in Pituitary and Adrenal Diseases in 2020
  Chang Ho Ahn, Jung Hee Kim
  Endocrinology and Metabolism.2021; 36(1): 51.     CrossRef
• Adrenal surgery: Review of 35 years experience in a single centre
  Enrico Battistella, Stefania Ferrari, Luca Pomba, Antonio Toniato
  Surgical Oncology.2021; 37: 101554.     CrossRef
• Adrenocortical Carcinoma: A Case of Missed Diagnosis
  Yusef Hazimeh, Carlie Sigel, Carsello Carie, Mathew Leinung, Zaynab Khalaf
  Cureus.2021;[Epub]     CrossRef
• Imagerie fonctionnelle en endocrinologie : nouveaux paradigmes à l’horizon 2020
  E. Marchal
  Médecine Nucléaire.2021; 45(3): 158.     CrossRef
• Adrenal Incidentaloma
  Caren G. Solomon, Electron Kebebew
  New England Journal of Medicine.2021; 384(16): 1542.     CrossRef
• Can Hematological Parameters Play a Role in the Differential Diagnosis of Adrenal Tumors?
  Mehmet Gürkan Arıkan, Göktan Altuğ Öz, Nur Gülce İşkan, Necdet Süt, İlkan Yüksel, Ersan Arda
  Uro.2021; 1(2): 39.     CrossRef
• Incidental Adrenal Nodules
  Daniel I. Glazer, Michael T. Corwin, William W. Mayo-Smith
  Radiologic Clinics of North America.2021; 59(4): 591.     CrossRef
• Antioxidant Barrier and Oxidative Damage to Proteins, Lipids, and DNA/RNA in Adrenal Tumor Patients
  Barbara Choromańska, Piotr Myśliwiec, Tomasz Kozłowski, Magdalena Łuba, Piotr Wojskowicz, Jacek Dadan, Hanna Myśliwiec, Katarzyna Choromańska, Anna Gibała, Anna Starzyńska, Małgorzata Żendzian-Piotrowska, Anna Zalewska, Mateusz Maciejczyk, Jos L. Quiles
  Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
• Laparoscopic Retroperitoneoscopic Removal of an Adrenal Hemangioma: a Case Report
  Kristin McCoy, Katherine Howe, Daniel Tershak
  Journal of Endocrine Surgery.2021; 21(3): 70.     CrossRef
• Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea
  Eu Jeong Ku, Chaelin Lee, Jaeyoon Shim, Sihoon Lee, Kyoung-Ah Kim, Sang Wan Kim, Yumie Rhee, Hyo-Jeong Kim, Jung Soo Lim, Choon Hee Chung, Sung Wan Chun, Soon-Jib Yoo, Ohk-Hyun Ryu, Ho Chan Cho, A Ram Hong, Chang Ho Ahn, Jung Hee Kim, Man Ho Choi
  Endocrinology and Metabolism.2021; 36(5): 1131.     CrossRef
• Cross-Talk Between Nitrosative Stress, Inflammation and Hypoxia-Inducible Factor in Patients with Adrenal Masses
  Barbara Choromańska, Piotr Myśliwiec, Tomasz Kozłowski, Magdalena Łuba, Piotr Wojskowicz, Jacek Dadan, Hanna Myśliwiec, Katarzyna Choromańska, Katarzyna Makarewicz, Anna Zalewska, Mateusz Maciejczyk
  Journal of Inflammation Research.2021; Volume 14: 6317.     CrossRef
• Cirugía laparoscópica en incidentaloma suprarrenal para el cirujano general: serie de casos
  Martín Adrián Bolívar-Rodríguez, Marcel Antonio Cázarez-Aguilar, Pedro Alejandro Magaña-Zavala, Francisco Magaña-Olivas, José Martín Niebla-Moreno
  Revista Mexicana de Cirugía Endoscópica.2021; 22(1): 8.     CrossRef
• Adrenal adenomas: what to do with them? Review 2
  S. Rybakov
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(3): 241.     CrossRef
• Laparoscopic adrenalectomy for giant adrenal tumours
  Alessio Giordano, Giovanni Alemanno, Carlo Bergamini, Andrea Valeri, Paolo Prosperi
  Journal of Minimal Access Surgery.2021; 17(1): 76.     CrossRef
• Is Follow-up of Adrenal Incidentalomas Always Mandatory?
  Giuseppe Reimondo, Alessandra Muller, Elisa Ingargiola, Soraya Puglisi, Massimo Terzolo
  Endocrinology and Metabolism.2020; 35(1): 26.     CrossRef
• Imaging Findings of Primary Adrenal Leiomyosarcoma: A Case Report
  Hye Ran Yoon, Dong Hee Park
  Journal of the Korean Society of Radiology.2020; 81(2): 459.     CrossRef
• WFUMB position paper on the management incidental findings: adrenal incidentaloma
  Christoph F. Dietrich, Jean Michel Correas, Yi Dong, Christian Nolsoe, Susan Campbell Westerway, Christian Jenssen
  Ultrasonography.2020; 39(1): 11.     CrossRef
• A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features
  Takamasa Ichijo, Hajime Ueshiba, Hajime Nawata, Toshihiko Yanase
  Endocrine Journal.2020; 67(2): 141.     CrossRef
• Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI
  Khaled M. Elsayes, Mohab M. Elmohr, Sanaz Javadi, Christine O. Menias, Erick M. Remer, Ajaykumar C. Morani, Akram M. Shaaban
  Abdominal Radiology.2020; 45(4): 982.     CrossRef
• Adrenal Incidentaloma
  Mark Sherlock, Andrew Scarsbrook, Afroze Abbas, Sheila Fraser, Padiporn Limumpornpetch, Rosemary Dineen, Paul M Stewart
  Endocrine Reviews.2020; 41(6): 775.     CrossRef
• A Web Application for Adrenal Incidentaloma Identification, Tracking, and Management Using Machine Learning
  Wasif Bala, Jackson Steinkamp, Timothy Feeney, Avneesh Gupta, Abhinav Sharma, Jake Kantrowitz, Nicholas Cordella, James Moses, Frederick Thurston Drake
  Applied Clinical Informatics.2020; 11(04): 606.     CrossRef
• Presentation and outcome of patients with an adrenal mass: A retrospective observational study
  Nadeema Rafiq, Tauseef Nabi, SajadAhmad Dar, Shahnawaz Rasool
  Clinical Cancer Investigation Journal.2020; 9(5): 198.     CrossRef
• Evaluation of Functionality and Growth Rates in Adrenal Incidentalomas: Single Center Experience
  Suna AVCI, Yüksel Aslı OZTURKMEN, Sayid ZUHUR, Gulkan OZKAN, Elif GUVEN, Nazan DEMİR, Yuksel ALTUNTAS
  Phoenix Medical Journal.2020; 2(3): 125.     CrossRef
• Percutaneous Adrenal Radiofrequency Ablation: A Short Review for Endocrinologists
  Byung Kwan Park
  Endocrinology and Metabolism.2020; 35(4): 750.     CrossRef
• Autonomous cortisol secretion in adrenal incidentalomas
  Marta Araujo-Castro, Miguel Antonio Sampedro Núñez, Mónica Marazuela
  Endocrine.2019; 64(1): 1.     CrossRef
• Primary adrenal schwannoma: a series of 31 cases emphasizing their clinicopathologic features and favorable prognosis
  Jun Zhou, Dandan Zhang, Wencai Li, Luting Zhou, Haimin Xu, Saifang Zheng, Chaofu Wang
  Endocrine.2019; 65(3): 662.     CrossRef
• Challenging risk factors for right and left laparoscopic adrenalectomy: A single centre experience with 272 cases
  Kadir Omur Gunseren, Mehmet Cagatay Cicek, Hakan Vuruskan, Yakup Kordan, Ismet Yavascaoglu
  International braz j urol.2019; 45(4): 747.     CrossRef
• A case report on 111In chloride bone marrow scintigraphy in management of adrenal myelolipoma
  Tatsuya Yamamoto, Mitsuru Koizumi, Atsushi Kohno, Noboru Numao, Kentaro Inamura
  Medicine.2019; 98(8): e14625.     CrossRef
• PRACTICAL ASPECTS OF LAPAROSCOPIC ADRENALECTOMY IN CHILDREN WITH BENIGN ADRENAL TUMORS
  I. V. Poddubny, R. S. Oganesyan, K. N. Tolstov, M. A. Kareva
  Russian Journal of Pediatric Surgery.2019; 23(5): 248.     CrossRef
• Incidental neuroblastoma with bilateral retinoblastoma: what are the chances?
  Kelsey Roelofs, Furqan Shaikh, William Astle, Brenda L. Gallie, Sameh E. Soliman
  Ophthalmic Genetics.2018; 39(3): 410.     CrossRef
• Surgical Considerations in Subclinical Cushing’s Syndrome. When is it Time to Operate?
  Alexander M. Nixon, C Aggeli, C Tserkezis, GN Zografos
  Hellenic Journal of Surgery.2018; 90(1): 27.     CrossRef
• Adrenal incidentaloma – diagnostic and treating problem – own experience
  Ryszard Pogorzelski, Krzysztof Celejewski, Sadegh Toutounchi, Ewa Krajewska, Tomasz Wołoszko, Małgorzata Szostek, Wawrzyniec Jakuczun, Patryk Fiszer, Małgorzata Legocka, Zbigniew Gałązka
  Open Medicine.2018; 13(1): 281.     CrossRef

Citations

Citations to this article as recorded by  

• Predictive ability of the Chinese visceral adiposity index for incident hypertension in working-aged Koreans
  Ju Young Jung, Chang-Mo Oh, Hyun chul Jo, Sung Keun Park
  Epidemiology and Health.2024; : e2024034.     CrossRef
• Association of the visceral adiposity index with arterial stiffness in elderly Chinese population
  Yifan Fan, Zhe Wang, Xiaotao Zhao, Shouling Wu, Hongjie Chi
  The American Journal of the Medical Sciences.2023; 365(3): 279.     CrossRef
• Visceral and subcutaneous fat, muscle mass, and liver volume as noninvasive predictors of the progress of non-alcoholic fatty liver disease
  Omar M. Mahmoud, Gehad Abd Elaziz Mahmoud, Haisam Atta, Wael A. Abbas, Hanan M. Ahmed, Mohamed A. A. Abozaid
  Egyptian Journal of Radiology and Nuclear Medicine.2023;[Epub]     CrossRef
• Association between Hypertriglyceridemic-Waist Phenotype and Metabolic Abnormalities in Hypertensive Adults
  Kyung-A SHIN, Myung Shin KANG
  Korean Journal of Clinical Laboratory Science.2023; 55(2): 113.     CrossRef
• Association of Hyper-Triglyceridemic Waist Phenotype and Diabetic Vascular Complication in the Chinese Population
  Kun Li, Bin Cao, Jing Ke, Longyan Yang, Dong Zhao
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2233.     CrossRef
• The relationship between hypertriglyceridemic wait-to-height ratio and hypertension–diabetes comorbidity among older adult
  Ping Zhang, Yangyang Xiong, Menghan Chen, Huaide Zhang, Nan Sun, Fan Wu, Jiayu Yang, Yongcheng Ren
  Frontiers in Public Health.2023;[Epub]     CrossRef
• Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population
  Yan Xuan, Ping Gao, Ying Shen, Sujie Wang, Xi Gu, Dou Tang, Xun Wang, FanFan Zhu, Leiqun Lu, Ling Chen
  Hormones.2022; 21(3): 437.     CrossRef
• The Association Between Hypertriglyceridemic-Waist Phenotype and Chronic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional METAL Study
  Yan Xuan, Wen Zhang, Yuying Wang, Bin Wang, Yi Chen, Fangzhen Xia, Kun Zhang, Qing Li, Ningjian Wang, Yingli Lu
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1885.     CrossRef
• Chinese Visceral Adiposity Index Is More Closely Associated With Hypertension and Prehypertension Than Traditional Adiposity Indices in Chinese Population: Results From the REACTION Study
  Binqi Li, Jie Wang, Xin Zhou, Yang Liu, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Association between hypertriglyceridemic-waist phenotype and cardiovascular disease: A cohort study and meta-analysis
  Xiaowei Zheng, Xiao Ren, Minglan Jiang, Longyang Han
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• The association between visceral adiposity index and leukocyte telomere length in adults: results from National Health and Nutrition Examination Survey
  Yifan Fan, Yulin Guo, Jiuchang Zhong, Hongjie Chi, Xiaotao Zhao, Pixiong Su, Jie Gao, Mulei Chen
  Aging Clinical and Experimental Research.2022; 34(9): 2177.     CrossRef
• Hypertriglyceridemic-waist phenotype is strongly associated with cardiovascular risk factor clustering in Chinese adolescents
  Rongrong Cai, Jinyu Zhou, Ling Bai, Yangyang Dong, Wenqing Ding
  Scientific Reports.2022;[Epub]     CrossRef
• Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran
  Behrooz Hamzeh, Yahya Pasdar, Narmin Mirzaei, Roya Safari Faramani, Farid Najafi, Ebrahim Shakiba, Mitra Darbandi
  Lipids in Health and Disease.2021;[Epub]     CrossRef
• Visceral adiposity index is positively associated with blood pressure: A systematic review
  Nathália Nogueira Leite, Bruna Clemente Cota, Ana Raquel Ernesto Manuel Gotine, Daniela Mayumi Usuda Prado Rocha, Patrícia Feliciano Pereira, Helen Hermana Miranda Hermsdorff
  Obesity Research & Clinical Practice.2021; 15(6): 546.     CrossRef
• The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits
  Begoña de Cuevillas, Ismael Alvarez-Alvarez, Jose I. Riezu-Boj, Santiago Navas-Carretero, J. Alfredo Martinez
  Scientific Reports.2021;[Epub]     CrossRef
• Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study
  Meizhen Gu, Weijun Huang, Xinyi Li, Yupu Liu, Fan Wang, Chao Fang, Ting Chen
  Nature and Science of Sleep.2021; Volume 13: 2165.     CrossRef
• The Visceral Adipose Index in Relation to Incidence of Hypertension in Chinese Adults: China Health and Nutrition Survey (CHNS)
  Yong Xue, Qun Shen, Chang Li, Zijian Dai, Tingchao He
  Nutrients.2020; 12(3): 805.     CrossRef
• Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
  Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
  Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
• Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study
  Rokhsareh Meamar, Masoud Amini, Ashraf Aminorroaya, Maryam Nasri, Majid Abyar, Awat Feizi
  World Journal of Diabetes.2020; 11(5): 202.     CrossRef
• Association between Visceral Adiposity Index and hypertension among Chinese Adults: a nationwide cross-sectional study in the China Health and Nutrition Survey
  Jing Yang, Hongxia Li, Lianhua Han, Lei Zhang, Yafeng Zhou
  Blood Pressure Monitoring.2020; 25(5): 271.     CrossRef
• Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population
  Minrui Xu, Mingtao Huang, Deren Qiang, Jianxin Gu, Yong Li, Yingzi Pan, Xingjuan Yao, Wenchao Xu, Yuan Tao, Yihong Zhou, Hongxia Ma, Ulrike Rothe
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis
  Yanbing Ding, Min Zhang, Lisheng Wang, Tao Yin, Ningzhi Wang, Jian Wu, Jiehua Zhi, Weiwei Chen, Keyan Wu, Weijuan Gong, Weiming Xiao, Zhenglei Xu, Guotao Lu
  Lipids in Health and Disease.2019;[Epub]     CrossRef
• Association between the Hypertriglyceridemic Waist Phenotype and Prediabetes in Chinese Adults Aged 40 Years and Older
  Kun Zhao, Shan-Shan Yang, Hai-Bin Wang, Kang Chen, Zhao-Hui Lu, Yi-Ming Mu
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Sex-specific relationship between visceral fat index and dyslipidemia in Chinese rural adults: The Henan Rural Cohort Study
  Zhongyan Tian, Yuqian Li, Zhenxing Mao, Songcheng Yu, Yanhua Wang, Xiaotian Liu, Runqi Tu, Haiqing Zhang, Xinling Qian, Xia Zhang, Lulu Zhang, Jingzhi Zhao, Lei Yin, Chongjian Wang
  Preventive Medicine.2018; 116: 104.     CrossRef
• Response: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
  Mohsen Janghorbani
  Endocrinology and Metabolism.2017; 32(4): 485.     CrossRef
• Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
  Eun-Jung Rhee
  Endocrinology and Metabolism.2017; 32(3): 396.     CrossRef

Citations

Citations to this article as recorded by  

• Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
  Monika Buraczynska, Jakub Golacki, Wojciech Zaluska
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 557.     CrossRef
• Hormonal and metabolic profiles of obese and nonobese type 2 diabetes patients: implications of plasma insulin, ghrelin, and vitamin D levels
  Hayder A. Giha, Dhuha M. B. AlDehaini, Faris E. Joatar, Muhalab E. Ali, Einas M. Al-Harbi, Ali A. Al Qarni
  Cardiovascular Endocrinology & Metabolism.2022;[Epub]     CrossRef
• Association of obesity in T2DM with differential polymorphism of ghrelin, growth hormone secretagogue receptor-1 and telomeres maintenance genes
  Hayder A. Giha, Faris E. Joatar, Dhuha M. B. AlDehaini, Zainab H. A. Malalla, Muhalab E. Ali, Ali A. Al Qarni
  Hormone Molecular Biology and Clinical Investigation.2022; 43(3): 297.     CrossRef
• TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice
  Nathalie Obadia, Giulia Andrade, Marina Leardini-Tristão, Letícia Albuquerque, Celina Garcia, Flavia Lima, Júlio Daleprane, Hugo C. Castro-Faria-Neto, Eduardo Tibiriçá, Vanessa Estato
  Journal of Neuroinflammation.2022;[Epub]     CrossRef
• Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
  Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Javed Iqbal Wani, Zia Ul Sabah, Mohammed Jeelani, Vijaya Marakala, Shahzada Khalid Sohail, Mohamed O’haj, Muffarah Hamid Alharthi, Mohannad Mohammad S. Alamri
  Journal of Personalized Medicine.2022; 12(5): 735.     CrossRef
• C-peptide is a predictor of telomere shortening: A five-year longitudinal study
  Racha Ghoussaini, Hani Tamim, Martine Elbejjani, Maha Makki, Lara Nasreddine, Hussain Ismaeel, Mona P. Nasrallah, Nathalie K. Zgheib
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Relationship Between Acyl and Desacyl Ghrelin Levels with Insulin Resistance and Body Fat Mass in Type 2 Diabetes Mellitus
  Pu Zang, Cui-Hua Yang, Jun Liu, Hai-Yan Lei, Wei Wang, Qing-Yu Guo, Bin Lu, Jia-Qing Shao
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 2763.     CrossRef
• The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study
  Amanda J. Vinson, Aran Thanamayooran, Bryce A. Kiberd, Kenneth West, Ferhan S. Siddiqi, Lakshman Gunaratnam, Karthik K. Tennankore
  Kidney360.2022; 3(10): 1738.     CrossRef
• Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP‐1, and insulin secretion
  Ayse G. Zengul, Sarah ET Hoover, Paula C. Chandler‐Laney
  Pediatric Obesity.2021;[Epub]     CrossRef
• The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
  Daria Skuratovskaia, Maria Vulf, Nataliya Chasovskikh, Aleksandra Komar, Elena Kirienkova, Egor Shunkin, Pavel Zatolokin, Larisa Litvinova
  Frontiers in Genetics.2021;[Epub]     CrossRef
• Анализ причин нарушения моторно-эвакуаторной функции желудка у больных с метаболическим синдромом
  Сергей Николаевич Чернуха , Ирина Александровна Вильцанюк
  Естественные и Технические Науки.2021; (№05): 220.     CrossRef
• Variation analysis of Ghrelin gene in Chinese patients with obesity, having polycystic ovarian syndrome
  Xiaomeng Wang, Fengxiang Qu, Chunlian Wang, Yan Wang, Dan Wang, Min Zhao, Xiangbing Yun, Qingmei Zheng, Lin Xu
  Gynecological Endocrinology.2020; 36(7): 594.     CrossRef
• Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population
  Edgar Alfonso Rivera-León, Mara Anaís Llamas-Covarrubias, Sergio Sánchez-Enríquez, Erika Martínez-López, Mercedes González-Hita, Iris Monserrat Llamas-Covarrubias
  BMC Endocrine Disorders.2020;[Epub]     CrossRef
• Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity
  Nataliia Vasylivna Gubina, Iryna Hryhorivna Kupnovytska, Vasyl Hryhorovych Mishchuk, Halyna Dmytrivna Markiv
  Journal of Medicine and Life.2020; 13(4): 530.     CrossRef
• Ghrelin fiber projections from the hypothalamic arcuate nucleus into the dorsal vagal complex and the regulation of glycolipid metabolism
  Manqing Su, Meixing Yan, Yanling Gong
  Neuropeptides.2019; 78: 101972.     CrossRef
• Ghrelin deficiency in patients with type 2 diabetes: the relationships with obesity, adipose tissue dysfunction and glucose variability
  V V Klimontov, D M Bulumbaeva, O N Fazullina, N B Orlov, V I Konenkov
  Terapevticheskii arkhiv.2019; 91(10): 28.     CrossRef
• The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis
  Cai-Shun Zhang, Liu-Xin Wang, Rui Wang, Yuan Liu, Li-Min Song, Jun-Hua Yuan, Bin Wang, Jing Dong
  Frontiers in Physiology.2018;[Epub]     CrossRef
• Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals
  Haseeb A. Khan, Samia H. Sobki, Aishah Ekhzaimy, Isra Khan, Mona A. Almusawi
  Saudi Journal of Biological Sciences.2018; 25(8): 1729.     CrossRef
• Leu72Met and Other Intronic Polymorphisms in theGHRLandGHSRGenes Are Not Associated with Type 2 Diabetes Mellitus, Insulin Resistance, or Serum Ghrelin Levels in a Saudi Population
  Faris Elbahi Joatar, Ali Ahmed Al Qarni, Muhalab E. Ali, Abdulaziz Al Masaud, Abdirashid M. Shire, Nagalla Das, Khalid Gumaa, Hayder A. Giha
  Endocrinology and Metabolism.2017; 32(3): 360.     CrossRef
• Expanded Normal Weight Obesity and Insulin Resistance in US Adults of the National Health and Nutrition Examination Survey
  Keilah E. Martinez, Larry A. Tucker, Bruce W. Bailey, James D. LeCheminant
  Journal of Diabetes Research.2017; 2017: 1.     CrossRef

Citations

Citations to this article as recorded by  

• Vildagliptin Sustained-release and Dapagliflozin Fixed-dose Combination in the Management of Type 2 Diabetes Mellitus: A Comprehensive Review
  Subhajyoti Ghosh, Mainak Mukhopadhyay, Mayur Agrawal, Mohammad Shahid, Mahak Lamba, Sudeep Jain, Ashish Prasad, Amit Gupta, Rohan Kesarkar, Sona Warrier, Abhijeet Pednekar
  International Journal of Diabetes and Technology.2024; 3(2): 49.     CrossRef
• Glycemic Variability in Pancreatogenic Diabetes Mellitus: characteristics, Risks, Potential Mechanisms, and Treatment Possibilities
  Yuyan Sun, Bing Lu, Yuanwen Hu, Yingqi Lv, Shao Zhong
  International Journal of General Medicine.2024; Volume 17: 4297.     CrossRef
• Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus
  Alanood A. Howsawi, Manal M. Alem
  Scientific Reports.2024;[Epub]     CrossRef
• What is Glycaemic Variability and which Pharmacological Treatment Options are Effective? A Narrative Review
  Juan Miguel Huertas Cañas, Maria Alejandra Gomez Gutierrez, Andres Bedoya Ossa
  European Endocrinology.2023; 19(2): 4.     CrossRef
• Glycemic Variability, Glycated Hemoglobin, and Cardiovascular Complications: Still a Dilemma in Clinical Practice
  Antonio Ceriello, Ali A. Rizvi, Manfredi Rizzo
  Advances in Therapy.2022; 39(1): 1.     CrossRef
• Contrasting Three Non-hypoglycemic Antidiabetic Drug Effects on Glycemic Control in Newly Diagnosed Type II Diabetes Mellitus: An Experimental Study
  Abdulhamza Hmood, Mohammed Almasoody, Hameed Hussein Al-Jameel
  Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 506.     CrossRef
• Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis
  SuA Oh, Sujata Purja, Hocheol Shin, Minji Kim, Eunyoung Kim
  Diabetes and Vascular Disease Research.2022;[Epub]     CrossRef
• Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
  Shangyu Chai, Ruya Zhang, Ye Zhang, Richard David Carr, Yiman Zheng, Swapnil Rajpathak, Miao Yu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
  Hae Jin Kim, In Kyung Jeong, Kyu Yeon Hur, Soo-Kyung Kim, Jung Hyun Noh, Sung Wan Chun, Eun Seok Kang, Eun-Jung Rhee, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(5): 689.     CrossRef
• Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study
  Manal M. Alem
  Heliyon.2022; 8(11): e11549.     CrossRef
• Effect of Hydroxychloroquine on Glycemic Variability in Type 2 Diabetes Patients Uncontrolled on Glimepiride and Metformin Therapy
  Rajesh Rajput, Suyasha Saini, Siddhant Rajput, Parankush Upadhyay
  Indian Journal of Endocrinology and Metabolism.2022; 26(6): 537.     CrossRef
• Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
  Seung-Hwan Lee, Kyung-Wan Min, Byung-Wan Lee, In-Kyung Jeong, Soon-Jib Yoo, Hyuk-Sang Kwon, Yoon-Hee Choi, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2021; 45(3): 339.     CrossRef
• Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
  Bao Sun, Zhiying Luo, Jiecan Zhou
  Cardiovascular Diabetology.2021;[Epub]     CrossRef
• CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review
  Anne-Esther Breyton, Stéphanie Lambert-Porcheron, Martine Laville, Sophie Vinoy, Julie-Anne Nazare
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Efficacy and safety profile of sitagliptin, vildagliptin, and metformin in newly diagnosed type 2 diabetic subjects
  Sahar Hossam Elhini, Amal K. Hussien, Ahmed Abd Elsamie Omran, Asmaa A. Elsayed, Haitham saeed
  Clinical and Experimental Pharmacology and Physiology.2021; 48(12): 1589.     CrossRef
• Vildagliptin ameliorates renal injury in type 2 diabetic rats by suppressing oxidative stress
  Fariba Aghahoseini, Alireza Alihemmati, Leila Hosseini, Reza Badalzadeh
  Journal of Diabetes & Metabolic Disorders.2020; 19(2): 701.     CrossRef
• Small changes in glucose variability induced by low and high glycemic index diets are not associated with changes in β-cell function in adults with pre-diabetes
  Kristina M. Utzschneider, Tonya N. Johnson, Kara L. Breymeyer, Lisa Bettcher, Daniel Raftery, Katherine M. Newton, Marian L. Neuhouser
  Journal of Diabetes and its Complications.2020; 34(8): 107586.     CrossRef
• Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
  Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
  Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
• Glycemic variability: adverse clinical outcomes and how to improve it?
  Zheng Zhou, Bao Sun, Shiqiong Huang, Chunsheng Zhu, Meng Bian
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
  Niki Katsiki, Ele Ferrannini
  Journal of Diabetes and its Complications.2020; 34(12): 107723.     CrossRef
• Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study
  Suhua Li, Xixiang Tang, Yanting Luo, Bingyuan Wu, Zhuoshan Huang, Zexiong Li, Long Peng, Yesheng Ling, Jieming Zhu, Junlin Zhong, Jinlai Liu, Yanming Chen
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes
  Xixiang Tang, Junlin Zhong, Hui Zhang, Yanting Luo, Xing Liu, Long Peng, Yanling Zhang, Xiaoxian Qian, Boxiong Jiang, Jinlai Liu, Suhua Li, Yanming Chen
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysis
  Xin Liu, Peng Men, Bo Wang, Gaojun Cai, Zhigang Zhao
  Lipids in Health and Disease.2019;[Epub]     CrossRef
• Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
  Fahmida Alam, Md. Asiful Islam, Mafauzy Mohamed, Imran Ahmad, Mohammad Amjad Kamal, Richard Donnelly, Iskandar Idris, Siew Hua Gan
  Scientific Reports.2019;[Epub]     CrossRef
• Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis
  Subin Lee, Heeyoung Lee, Yoonhye Kim, EunYoung Kim
  Scientific Reports.2019;[Epub]     CrossRef
• Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes
  Guillermo E. Umpierrez, Boris P. Kovatchev
  The American Journal of the Medical Sciences.2018; 356(6): 518.     CrossRef

Citations

Citations to this article as recorded by  

• Metabolic hormones are integral regulators of female reproductive health and function
  Faria Athar, Muskan Karmani, Nicole M. Templeman
  Bioscience Reports.2024;[Epub]     CrossRef
• Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review
  Archita Tiwari, Arti Verma, Shrishti Mishra, Bharat Mishra
  International Journal of Current Innovations in Advanced Research.2024; : 1.     CrossRef
• Efficacy Confirmation Test of Black Cumin (Nigella sativa L.) Seeds Extract Using a High-Fat Diet Mouse Model
  Khawaja Muhammad Imran Bashir, Joo Wan Kim, Jong-Kyu Kim, Yoon-Seok Chun, Jae-Suk Choi, Sae-Kwang Ku
  Metabolites.2023; 13(4): 501.     CrossRef
• Body mass index, menstruation, acne, and hirsutism of polycystic ovary syndrome in women: A cross-sectional study
  Jung-Hee Kim, Oksoo Kim, Heeja Jung, Yanghee Pang, Hyunju Dan
  Health Care for Women International.2022; 43(1-3): 85.     CrossRef
• A cross-sectional study on prevalence of menstrual problems, lifestyle, mental health, and PCOS awareness among rural and urban population of Punjab, India
  Priya Sharma, Mandeep Kaur, Sachin Kumar, Preeti Khetarpal
  Journal of Psychosomatic Obstetrics & Gynecology.2022; 43(3): 349.     CrossRef
• The global pandemic and changes in women’s reproductive health: an observational study
  Liya Haile, Niels van de Roemer, Kristina Gemzell-Danielsson, Josep Perelló Capó, Iñaki Lete Lasa, Silvia Vannuccini, Martin C. Koch, Thomas Hildebrandt, Joaquim Calaf
  The European Journal of Contraception & Reproductive Health Care.2022; 27(2): 102.     CrossRef
• A STUDY TO ESTABLISH RELATIONSHIP BETWEEN VARIOUS FACTORS WITH MENSTRUAL IRREGULARITY AMONG RURAL WOMEN IN BHOPAL DISTRICT, MADHYA PRADESH
  Shweta Singh, Avadhesh Diwakar
  INDIAN JOURNAL OF APPLIED RESEARCH.2022; : 5.     CrossRef
• The effects of obesity on the menstrual cycle
  Khalida Itriyeva
  Current Problems in Pediatric and Adolescent Health Care.2022; 52(8): 101241.     CrossRef
• The association between obesity and weight loss after bariatric surgery on the vaginal microbiota
  Olivia Raglan, David A. MacIntyre, Anita Mitra, Yun S. Lee, Ann Smith, Nada Assi, Jaya Nautiyal, Sanjay Purkayastha, Marc J. Gunter, Hani Gabra, Julian R. Marchesi, Phillip R. Bennett, Maria Kyrgiou
  Microbiome.2021;[Epub]     CrossRef
• Do women with HIV/AIDS on anti-retroviral therapy have a lower incidence of symptoms associated with menstrual dysfunction?
  Nicola Tempest, Damitha N Edirisinghe, Steven Lane, Dharani K Hapangama
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2021; 265: 137.     CrossRef
• Influence of overweight and obesity on the development of reproductive disorders in women
  O.S. Payenok
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(7): 575.     CrossRef
• Diabetes: a metabolic and reproductive disorder in women
  Eleanor P Thong, Ethel Codner, Joop S E Laven, Helena Teede
  The Lancet Diabetes & Endocrinology.2020; 8(2): 134.     CrossRef
• Menstrual Cycle Length in Women Ages 20-30 years in Makassar
  Andi Asmawati Azis, N Kurnia, Hartati, Andi Bida Purnamasari
  Journal of Physics: Conference Series.2018; 1028: 012019.     CrossRef
• Body Weight Changes in Obese Women and Menstruation
  Jung Hee Kim
  Endocrinology and Metabolism.2017; 32(2): 219.     CrossRef
• Nutritional Counseling Promotes Changes in the Dietary Habits of Overweight and Obese Adolescents with Polycystic Ovary Syndrome
  Adriana Lúcia Carolo, Maria Célia Mendes, Ana Carolina Japur de Sá Rosa e Silva, Carolina Sales Vieira, Marcos Felipe Silva de Sá, Rui Alberto Ferriani, Rosana Maria dos Reis
  Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics.2017; 39(12): 692.     CrossRef

Citations

Citations to this article as recorded by  

• Reliability of ultrasound measurements of muscle thickness and echointensity in older adults with type 2 diabetes
  Kirsten E. Bell, Michael T. Paris, Maryia Samuel, Marina Mourtzakis
  WFUMB Ultrasound Open.2024; 2(1): 100032.     CrossRef
• Precision MRI phenotyping of muscle volume and quality at a population scale
  Marjola Thanaj, Nicolas Basty, Brandon Whitcher, Elena P. Sorokin, Yi Liu, Ramprakash Srinivasan, Madeleine Cule, E. Louise Thomas, Jimmy D. Bell
  Frontiers in Physiology.2024;[Epub]     CrossRef
• Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments
  Ever Espino-Gonzalez, Emilie Dalbram, Rémi Mounier, Julien Gondin, Jean Farup, Niels Jessen, Jonas T. Treebak
  Cell Metabolism.2024; 36(6): 1204.     CrossRef
• Association of daily carbohydrate intake with intermuscular adipose tissue in Korean individuals with obesity: a cross-sectional study
  Ha-Neul Choi, Young-Seol Kim, Jung-Eun Yim
  Nutrition Research and Practice.2024; 18(1): 78.     CrossRef
• Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling
  Marcelo Flores-Opazo, Daniel Kopinke, Françoise Helmbacher, Rodrigo Fernández-Verdejo, Mauro Tuñón-Suárez, Gordon S. Lynch, Osvaldo Contreras
  Molecular Aspects of Medicine.2024; 97: 101277.     CrossRef
• Intermuscular adipose tissue in metabolic disease
  Bret H. Goodpaster, Bryan C. Bergman, Andrea M. Brennan, Lauren M. Sparks
  Nature Reviews Endocrinology.2023; 19(5): 285.     CrossRef
• Muscle function and architecture in children with juvenile idiopathic arthritis
  Pierre Bourdier, Anthony Birat, Emmanuelle Rochette, Éric Doré, Daniel Courteix, Frédéric Dutheil, Bruno Pereira, Sébastien Ratel, Etienne Merlin, Pascale Duché
  Acta Paediatrica.2021; 110(1): 280.     CrossRef
• NLRP3 Inflammasome: Potential Role in Obesity Related Low-Grade Inflammation and Insulin Resistance in Skeletal Muscle
  Gonzalo Jorquera, Javier Russell, Matías Monsalves-Álvarez, Gonzalo Cruz, Denisse Valladares-Ide, Carla Basualto-Alarcón, Genaro Barrientos, Manuel Estrada, Paola Llanos
  International Journal of Molecular Sciences.2021; 22(6): 3254.     CrossRef
• Intermuscular Fat Content in Young Chinese Men With Newly Diagnosed Type 2 Diabetes: Based on MR mDIXON-Quant Quantitative Technique
  Fuyao Yu, Bing He, Li Chen, Fengzhe Wang, Haidong Zhu, Yanbin Dong, Shinong Pan
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• A Valid and Precise Semiautomated Method for Quantifying Intermuscular Fat Intramuscular Fat in Lower Leg Magnetic Resonance Images
  Andy K.O. Wong, Eva Szabo, Marta Erlandson, Marshall S. Sussman, Sravani Duggina, Anny Song, Shannon Reitsma, Hana Gillick, Jonathan D. Adachi, Angela M. Cheung
  Journal of Clinical Densitometry.2020; 23(4): 611.     CrossRef
• Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
  Alan Chait, Laura J. den Hartigh
  Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef
• Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial
  Amy M Goss, Barbara Gower, Taraneh Soleymani, Mariah Stewart, May Pendergrass, Mark Lockhart, Olivia Krantz, Shima Dowla, Nikki Bush, Valene Garr Barry, Kevin R. Fontaine
  Nutrition & Metabolism.2020;[Epub]     CrossRef
• Local In Vivo Measures of Muscle Lipid and Oxygen Consumption Change in Response to Combined Vitamin D Repletion and Aerobic Training in Older Adults
  D. Thomas, David Schnell, Maja Redzic, Mingjun Zhao, Hideat Abraha, Danielle Jones, Howard Brim, Guoqiang Yu
  Nutrients.2019; 11(4): 930.     CrossRef
• Impact of different ectopic fat depots on cardiovascular and metabolic diseases
  Daniele Ferrara, Fabrizio Montecucco, Franco Dallegri, Federico Carbone
  Journal of Cellular Physiology.2019; 234(12): 21630.     CrossRef
• Differential Relationship between Intermuscular Adipose Depots with Indices of Cardiometabolic Health
  Robert E. Bergia, Jung Eun Kim, Wayne W. Campbell
  International Journal of Endocrinology.2018; 2018: 1.     CrossRef
• Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: The Kuakini Honolulu Heart Program
  Kiyoshi Sanada, Randi Chen, Bradley Willcox, Tomoyuki Ohara, Aida Wen, Cody Takenaka, Kamal Masaki
  Nutrition.2018; 46: 97.     CrossRef

Citations

Citations to this article as recorded by  

• Replicating human characteristics: A promising animal model of central fatigue
  Yifei Zhang, Zehan Zhang, Qingqian Yu, Bijuan Lan, Qinghuan Shi, Ruting Li, Ziheng Jiao, Weiyue Zhang, Feng Li
  Brain Research Bulletin.2024; 212: 110951.     CrossRef
• Evaluation of physicians' approaches for the management of patients with diabetes during Ramadan in Iraq
  Majid Alabbood, Rafid Alameri, Yasameen Alsaffar
  Diabetes Research and Clinical Practice.2023; 195: 110188.     CrossRef
• The physiological changing and the recommended management plans for the diabetic patient during Ramadan fasting; A review article
  Abeer Alhaj, Omar F Shatnawi
  JAP Academy Journal.2023;[Epub]     CrossRef
• Incidence of diabetic ketoacidosis does not differ in Ramadan compared to other months and seasons: results from a 6-year multicenter study
  Fateen Ata, Adeel Ahmad Khan, Ibrahim Khamees, Mohammed Bashir
  Current Medical Research and Opinion.2023; 39(8): 1061.     CrossRef
• Evidence-based risk factors for major complications during Ramadan fasting in people with diabetes grouped under IDF-DAR risk categories
  Rahmatullah, Muhammad Yakoob Ahmedani, Abdul Basit, Shagufta Zia, Imran Hasan, Qazi Masroor, Abrar Shaikh, Jehangir Khan, Waheed Iqbal
  Diabetes Research and Clinical Practice.2022; 185: 109234.     CrossRef
• A Systematic Review of Insulin Management Recommendations to Improve Glycemic Control and Reduce Hypoglycemic Events During Ramadan Fasting in Patients With Insulin-Requiring Type 2 Diabetes
  Alexander Kieu, Ashley Iles, Moien AB Khan, Linda Östlundh, Duston Boyd, MoezAlIslam Ezzat Faris
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes
  Mohamed Hassanein, Zanariah Hussein, Inass Shaltout, Wan Juani Wan Seman, Chin Voon Tong, Nurain Mohd Noor, Mehmet Akif Buyukbese, Lobna El Tony, Gamal Mohamed Shaker, Reem M. Alamoudi, Khadija Hafidh, M. Fariduddin, Mohammed A. Batais, Shehla Shaikh, Pr
  Diabetes Research and Clinical Practice.2021; 173: 108674.     CrossRef
• Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial
  Louay Y. Zaghlol, Amir F. Beirat, Justin Z. Amarin, Amro M. Hassoun Al Najar, Yazan Y. Hasan, Abdallah Qtaishat, Michael E. Tierney, Raja Y. Zaghlol, Ayman A. Zayed
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
  Mahmoud Ibrahim, Melanie J Davies, Ehtasham Ahmad, Firas A Annabi, Robert H Eckel, Ebtesam M Ba-Essa, Nuha Ali El Sayed, Amy Hess Fischl, Pamela Houeiss, Hinde Iraqi, Ines Khochtali, Kamlesh Khunti, Shabeen Naz Masood, Safia Mimouni-Zerguini, Samad Shera,
  BMJ Open Diabetes Research & Care.2020; 8(1): e001248.     CrossRef
• Ramadan and Diabetes: A Narrative Review and Practice Update
  Syed H. Ahmed, Tahseen A. Chowdhury, Sufyan Hussain, Ateeq Syed, Ali Karamat, Ahmed Helmy, Salman Waqar, Samina Ali, Ammarah Dabhad, Susan T. Seal, Anna Hodgkinson, Shazli Azmi, Nazim Ghouri
  Diabetes Therapy.2020; 11(11): 2477.     CrossRef
• A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting
  Fauzia Rashid, Elamin Abdelgadir
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(2): 1413.     CrossRef
• Risk of diabetic ketoacidosis during Ramadan fasting: A critical reappraisal
  Salem A. Beshyah, Tahseen A. Chowdhury, Nazim Ghouri, Abdulfattah A. Lakhdar
  Diabetes Research and Clinical Practice.2019; 151: 290.     CrossRef